Bacterial Cellulose Templates for Nano-Hydroxyapatite Fibre Synthesis by DeMello, Jordan A.
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
2-24-2012 12:00 AM 
Bacterial Cellulose Templates for Nano-Hydroxyapatite Fibre 
Synthesis 
Jordan A. DeMello 
The University of Western Ontario 
Supervisor 
Dr. Wankei Wan 
The University of Western Ontario 
Graduate Program in Biomedical Engineering 
A thesis submitted in partial fulfillment of the requirements for the degree in Master of 
Engineering Science 
© Jordan A. DeMello 2012 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Biomaterials Commons 
Recommended Citation 
DeMello, Jordan A., "Bacterial Cellulose Templates for Nano-Hydroxyapatite Fibre Synthesis" (2012). 
Electronic Thesis and Dissertation Repository. 397. 
https://ir.lib.uwo.ca/etd/397 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
Title Page 
 
 
BACTERIAL CELLULOSE TEMPLATES FOR NANO-
HYDROXYAPATITE FIBRE SYNTHESIS 
 
 
 
(Thesis format: Monograph) 
 
 
by 
 
 
Jordan A. DeMello 
 
 
 
Graduate Program in Biomedical Engineering 
 
 
 
A thesis submitted in partial fulfillment 
of the requirements for the degree of 
Master of Engineering Science 
 
 
 
The School of Graduate and Postdoctoral Studies 
The University of Western Ontario 
London, Ontario, Canada 
 
 
 
 
 
 
 
© Jordan A. DeMello, 2012  
 ii 
 
The UNIVERSITY of WESTERN ONTARIO 
The School of Graduate and Postdoctoral Studies 
Certificate of Examination 
 
CERTIFICATE OF EXAMINATION 
 
 
 
Supervisor Examiners 
 
 
__________________________________ 
Dr. Wankei Wan 
 
__________________________________ 
Dr. Argyrios Margaritis 
 
  
__________________________________ 
Dr. Dimitre Karamanev 
 
  
__________________________________ 
Dr. Don Hewson 
 
 
 
The thesis by 
 
Jordan A. DeMello 
 
 
entitled: 
 
Bacterial Cellulose Templates for Nano-Hydroxyapatite Fibre Synthesis 
 
 
is accepted in partial fulfillment of the 
requirements for the degree of 
Master of Engineering Science 
 
 
 
 
Date: _____________________________ ____________________________________ 
Chair of the Thesis Examination Board 
  
 iii 
 
Abstract 
Abstract 
Guided bone regeneration is a medical procedure which induces in vivo re-growth of 
bone using membranes and osteopromoting fillers. In this work, bacterial cellulose fibres 
were isolated and used as a basis for biomimetic hydroxyapatite growth, with the ultimate 
goal of producing GBR filler materials. Acetobacter xylinum generated BC using various 
carbon sources. Fibres were treated with phosphoric acid to phosphorylate functional 
groups and preconditioned with calcium to nucleate the HA. Simulated body fluid (SBF) 
furthered the growth. Over 14 days, the product was characterized via EDX, SEM, FTIR, 
and XRD. The effect of media composition, phosphorylation time, pre-treatment, and 
structure on the resultant composites was examined. Samples possessed a Ca-to-P ratio as 
high as 1.45±0.92, encompassing the HA standard of 1.67. Higher ratios were observed 
on the surface of pellicles, implying crystal deposition. Results indicate potential in three-
dimensional samples and a basis for further BC-HA scaffold optimization for GBR. 
 
 
 
 
 
 
Keywords: guided bone regeneration, bacterial cellulose, hydroxyapatite, biomimetic 
synthesis, simulated body fluid, Acetobacter xylinum, phosphorylation. 
  
 iv 
 
Acknowledgements 
Acknowledgements 
I would like to express my deepest gratitude to my parents, first and foremost. Everyone 
always says that their parents supported them throughout the course of their degree; I do 
not know of a time when my family has not supported me. Thank you for your love and 
support since time immemorial. 
To my friends, for being yourselves. We`ve had our ups and downs, but you are the 
people that I aspire to be. To Adam Kirchhefer and Allison Hill. To Jeff Hujan. To Brian 
Chan. To the entire UWO Fencing Club and Executives. To Abe, Marco, Erik, Rizwan, 
Helen, and the entire multitude of international people who I have met in my time here at 
Western. Thank you for being the instrumental motivating factor in the existence of this 
document, as well as being an outlet when writing became too difficult. 
To my professors, for providing me with the access and freedom to pursue my ideals, and 
the diligence to tell me when I was being unrealistic. To Dr. Wan, for being a fount of 
knowledge in the field and for supervising me over the last couple of years. 
To my lab, for being an unbounded source of data and information, and for providing me 
with the scientific contacts needed when I started down this road. To the late Dr. Kenneth 
Wong, for his help in procuring all the SEM and EDX spectra. To Donna Padavan and 
Xinsheng Li for their advice, revisions, and constant assistance in characterization 
experiments. 
To those I have TAed. Ironically, I think I have learned more about myself through you, 
than I have afforded you in return. 
To The University of Western Ontario; for seeing something in me many years ago. 
 
  
 v 
 
Table of Contents 
 
Title Page ......................................................................................................................................... i 
Certificate of Examination ............................................................................................................ ii 
Abstract .......................................................................................................................................... iii 
Acknowledgements ....................................................................................................................... iv 
List of Figures ............................................................................................................................... vii 
List of Tables ................................................................................................................................. ix 
List of Abbreviations ..................................................................................................................... x 
1.0 Introduction .............................................................................................................................. 1 
1.1 Overview ............................................................................................................................... 1 
1.2 Thesis Objectives ................................................................................................................... 4 
2.0 Background and Literature Review ....................................................................................... 5 
2.1 Tissue Engineering of Bone .................................................................................................. 5 
2.2 Bone Biology and Physiology ............................................................................................... 7 
2.3 Guided Bone Regeneration .................................................................................................. 13 
2.3.1 Brief Historical Background of Guided Bone Regeneration (GBR) ............................. 16 
2.3.2 Principles of Guided Bone Regeneration ...................................................................... 17 
2.4 Material Selection ................................................................................................................ 19 
2.4.1 Cellulose ....................................................................................................................... 19 
2.4.2 Hydroxyapatite .............................................................................................................. 22 
2.5 Biomimetically Synthesized Composites via Simulated Body Fluid .................................. 25 
2.6 Bacterial Cellulose-Hydroxyapatite Composites ................................................................. 31 
3.0 Materials and Methods .......................................................................................................... 36 
3.1 General Procedure ............................................................................................................... 36 
3.2 Stages of Bacterial Cellulose Growth .................................................................................. 38 
3.2.1 Apparatus ...................................................................................................................... 38 
3.2.2 Procedure ...................................................................................................................... 39 
3.3 Phosphorylation ................................................................................................................... 42 
3.3.1 Apparatus ...................................................................................................................... 42 
3.3.2 Procedure ...................................................................................................................... 42 
3.4 Pre-treatment ....................................................................................................................... 43 
 vi 
 
3.5 Hydroxyapatite Growth ....................................................................................................... 44 
3.5.1 Preparation of SBF ........................................................................................................ 45 
3.6 Characterization ................................................................................................................... 49 
3.6.1 Fourier Transform Infrared Spectroscopy ..................................................................... 49 
3.6.2 Scanning Electron Microscopy ..................................................................................... 50 
3.6.3 Energy Dispersive X-ray Spectroscopy ........................................................................ 50 
3.6.4 X-ray Diffraction .......................................................................................................... 51 
4.0 Results and Discussion ........................................................................................................... 52 
4.1 Overview ............................................................................................................................. 52 
4.2 Production of BC using Maple Syrup as a Carbon Source .................................................. 53 
4.2.1 BC Characterization ...................................................................................................... 56 
4.3 Phosphorylation of BC ........................................................................................................ 60 
4.3.1 Characterization of Phosphorylated BC ........................................................................ 61 
4.3.2 Characterization of Phosphorylated BC After Treatment in SBF ................................. 70 
4.4 Effectiveness of Pre-treatment of BC .................................................................................. 78 
4.4.1 SEM Characterization ................................................................................................... 79 
4.4.2 EDX Characterization ................................................................................................... 83 
4.4.3 Crystallite Dimensional Analysis .................................................................................. 84 
4.5 Characterization of HA ........................................................................................................ 87 
4.6 Variations in Choice of Pre-treatment Media, and Cellulose Morphology in HA Growth . 98 
4.6.1 HA-Biofill® Composites .............................................................................................. 99 
4.6.2 Calcium Hydroxide Versus Calcium Chloride ........................................................... 100 
4.6.3 Effect of Pre-treatment Methodologies Internally Within the Pellicle ....................... 104 
5.0 Conclusions and Future Work ............................................................................................ 110 
6.0 References ............................................................................................................................. 115 
7.0 Curriculum Vitæ .................................................................................................................. 121 
 
   
 vii 
 
List of Figures 
List of Figures 
Figure 2.2.1: Bone microstructure ...................................................................................... 9 
Figure 2.2.2: Bone physiology .......................................................................................... 11 
Figure 2.3.1: Guided bone regeneration summary ............................................................ 15 
Figure 2.4.1.1: The repeating unit of pure cellulose ......................................................... 20 
Figure 2.4.2.1: Crystal structure of pure hydroxyapatite .................................................. 22 
Figure 2.6.1: Proposed means of functional group replacement on bacterial cellulose 
backbone ........................................................................................................................... 32 
Figure 3.1.1: Flowchart for the production of hollow hydroxyapatite fibres for guided 
bone regeneration .............................................................................................................. 37 
Figure 3.2.1.1: Continuous baffle flask growth of bacterial cellulose over the course of 14 
days ................................................................................................................................... 38 
Figure 3.3.1.1: Experimental set-up for the phosphorylation of bacterial cellulose. ........ 42 
Figure 4.2.1: Chemical structure of fructose .................................................................... 54 
Figure 4.2.2: Chemical structure of sucrose ..................................................................... 54 
Figure 4.2.3: Weight analysis of dry cellulose per litre of prepared growth media ......... 55 
Figure 4.2.1.1: SEM of fibres formed from fructose media ............................................. 57 
Figure 4.2.1.2: Fibre diameters for fibres formed from fructose media ........................... 57 
Figure 4.2.1.3: SEM of fibres formed from maple syrup based media ............................ 58 
Figure 4.2.1.4: Fibre diameters for fibres formed from maple syrup ............................... 58 
Figure 4.3.1.1: Scanning Electron Microscopy (SEM) outputs of a) untreated BC and b) 2 
hour phosphorylated BC ................................................................................................... 62 
Figure 4.3.1.2: Statistical distribution of fibre diameters in both a) bacterial cellulose 
(105.5 ± 26.0 nm) and b) 2-hour phosphorylated BC (56.7 ± 16.5 nm) ........................... 63 
Figure 4.3.1.3: SEMs of BC fibres after 1, 2, and 4 hours of phosphorylation ................ 64 
Figure 4.3.1.4: Distribution of BC fibre diameters for samples exposed to 1, 2, and 4 
hours of phosphorylation .................................................................................................. 64 
Figure 4.3.1.5: Sample expansion (950 to 1200 cm-1) of an FTIR taken of a bacterial 
cellulose sample (red), a BC sample after 2 hours of phosphorylation (green) and the 
same sample after 14 days in SBF (blue) .......................................................................... 65 
Figure 4.3.1.6: P-to-C ratio for BC samples after 1, 2, and 4 hours of phosphorylation .. 67 
Figure 4.3.1.7: Titration curve for a two hour phosphorylated cellulose sample ............. 69 
Figure 4.3.2.2: The Ca-to-P and P-to-C ratios as functions of the number of hours of 
phosphorylation after week long reaction in SBF............................................................. 73 
Figure 4.3.2.3: Ca-to-P molar ratio for samples undergoing 1, 2, or 4 hours of 
phosphorylation time and subsequent SBF reaction ......................................................... 75 
 viii 
 
Figure 4.3.2.4: P-to-C ratio for samples undergoing 1, 2, or 4 hours of phosphorylation 
and subsequent SBF reaction ............................................................................................ 76 
Figure 4.4.1.1: SEM of pre-treated BC fibres after 3 days in SBF ................................... 79 
Figure 4.4.1.2: SEM of untreated BC fibres after 3 days in SBF ..................................... 80 
Figure 4.4.1.3: Comparison of pre-treated and non-pre-treated samples of BC (3-day 
immersion in CaCl2) before (left) and after (right) 14-day term in SBF .......................... 82 
Figure 4.4.2.1: Observed Ca-to-P molar ratio of the bacterial cellulose/hydroxyapatite 
fibre sample over the course of 14 days ............................................................................ 83 
Figure 4.4.3.1: Major HA crystallite dimension (length) as a function of the length of 
time in SBF ....................................................................................................................... 84 
Figure 4.4.3.2: Minor HA crystallite dimension (diameter) as a function of the length of 
time in SBF ....................................................................................................................... 86 
Figure 4.5.1.1: FTIR for hydroxyapatite prepared via biomimetic conditions ................. 88 
Figure 4.5.1.2: FTIRs for, from bottom to top; BC-PO4H2, 1 hr long phosphorylated BC-
HA, 2 hr long phosphorylated BC-HA, 4 hr long phosphorylated BC-HA, 2 hr long 
phosphorylated HA-Biofill®, and “pure” hydroxyapatite procured via a chemical 
precipitation method in conjunction with SBF ................................................................. 90 
Figure 4.5.1.3: Expansion (900 – 1900 cm-1) of the characteristic region of HA-BC 
composites shown in figure 4.5.1.2 .................................................................................. 92 
Figure 4.5.1.4: A sample EDX pattern for the BC-HA pellicle samples .......................... 94 
Figure 4.5.1.5: Sample XRD of the produced HA crystallites ......................................... 96 
Figure 4.6.1.1: SEMs of the HA-Biofill® composites ..................................................... 99 
Figure 4.6.2.1: Cross section of a BC pellicle pre-treated with calcium chloride .......... 102 
Figure 4.6.2.2: Cross section of a BC pellicle pre-treated with calcium hydroxide ....... 103 
Figure 4.6.3.1: Molar ratio (Calcium to Phosphorus) of the pellicle immersed in CaCl2 
pre-treatment as a function of the interstitial thickness .................................................. 104 
Figure 4.6.3.2: Molar ratio (Calcium to Phosphorus) of the pellicle immersed in Ca(OH)2 
pre-treatment as a function of the interstitial thickness .................................................. 105 
Figure 4.6.3.3: Phosphorus content as a function of distance into the sample ............... 106 
  
 ix 
 
List of Tables 
List of Tables 
Table 3.2.2.1: Reagents for Acetobacter xylinum growth medium ................................................ 39 
Table 3.5.1: Ionic concentrations in regular (1.0x) SBF and human blood plasma ....................... 44 
Table 3.5.1.1: Reagents for Kokubo’s simulated body fluid (1.5x) ............................................... 46 
Table 4.2.1.1: Summary of EDX results for BC ............................................................................ 59 
Table 4.3.1.1: Wavelength assignment of most significant PO43-/HA peaks (950-1200 cm-1) ...... 66 
Table 4.3.1.2: DSP as a function of length of phosphorylation time .............................................. 68 
Table 4.5.1.1: EDX results for biomimetically produced HA (Ca10(PO4)6OH2) ........................... 95 
Table 4.5.1.2: Assignment of peaks from XRD shown in figure 4.5.1.5 and corresponding 
diffraction planes ........................................................................................................................... 97 
 
  
 x 
 
List of Abbreviations 
List of Abbreviations 
AFM Atomic Force Microscopy 
ATCC American Type Culture Collection 
ATR Attenuated Total Reflectance 
BC Bacterial Cellulose 
BC-HA Bacterial Cellulose/Hydroxyapatite composite 
BC-PO4Ca Calcium Pre-treated Phosphorylated Bacterial Cellulose 
BC-PO4H2 Phosphorylated Bacterial Cellulose 
BMP Bone Morphogenetic Protein 
DMF Dimethylformamide 
DSP Degree of Substitution (by Phosphate) 
EDX Energy Dispersive X-ray Spectroscopy 
FTIR Fourier Transform Infrared Spectroscopy 
GBR/GTR Guided Bone Regeneration/Guided Tissue Regeneration 
HA Hydroxyapatite 
hBMSC human Bone Marrow Stromal Cells 
ICP-AES Inductively Coupled Plasma Atomic Emission Spectroscopy 
IGF Insulin-like Growth Factor 
OCP Octacalcium Phosphate 
PAA Polyacrylamide 
PDGF Platelet-Derived Growth Factor 
PE Polyethylene 
PMMA Polymethylmethacrylate 
PTFE Polytetrafluoroethylene 
SBF Simulated Body Fluid 
SEM Scanning Electron Microscopy 
TCP Tricalcium Phosphate 
TEM Transmission Electron Microscopy 
TGF-β Transforming Growth Factor β 
TRIS Tris(hydroxymethyl)aminomethane 
XRD X-ray Diffraction Spectroscopy 
α-MEM α-Minimal Essential Medium 
  
1 
 
 
Chapter One 
1.0 Introduction 
1.1 Overview 
 
Hard tissues, such as that of bone, are exquisite structures in both composition and 
function. They form naturally through a biomineralization process, by which an inorganic 
phase is sequentially and meticulously overlaid upon an organic template. In attempting 
to replicate the physiological capabilities of vertebrates, scientists, over the last several 
decades, have made strides in bone tissue engineering and implantable devices, the most 
promising of which are biomimetic in nature. That is to say, the natural process of bone 
growth is partially mimicked in vitro, before being implanted into a patient. Nevertheless, 
the ideal combination of organic substrate and inorganic adjunct has managed to elude 
the scientific community, mainly due to failings in structural integrity, adaptability and 
cellular response. 
Cellulose, as a long-chain saccharide polymer, has been used extensively in the 
biomedical field for its high degree of biocompatibility and significant tensile strength. 
This glucosidic biomaterial is usually obtained through the harvesting of fibrous plant 
tissue, although, recently, cellulotic growth via bacteria has come to the forefront due to 
higher crystallinity, larger degree of polymerization, nano-scaled diameter and simplified 
purification[1]. In addition, the high hydrophilicity and surface-area-to-volume ratios of 
the product fibres lend themselves well to industrial applications in the form of 
composites, thickeners, as well as membranes and coatings in a variety of fields[1, 2]. 
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Comparatively, hydroxyapatite (HA), a crystalline, calcium phosphate-based mineral 
found in bone tissue, has been used, to a large extent, as a major component in the 
development of osteal tissue regeneration, implants and bone grafts, though it lacks a 
directed crystal structure and the ability to be moulded. Instead, the millimetre-scale 
powder must be adsorbed onto surfaces, or poured in open cavities in bone and covered 
with a semi-permeable membrane in a process known as Guided Bone Regeneration 
(GBR). Unfortunately, this has the added side effect of poorly maintained scaffolding 
(due to the large size discrepancy between the 20 micrometer bone cells and the 
macromolecular particles), and the instability of the implant site.  
To overcome this problem, the addition of nanometre-sized hydroxyapatite coatings onto 
natural polysaccharide polymers such as chitin[3], chitosan[4], and cotton[5] has been 
reported, in recent years, with varying degrees of success. The use of bacterial cellulose 
(BC) fibres for such applications, however, has long been unexplored. Recent articles[6, 
7] have dabbled in BC pellicles (or ‘sheets’) for the seeding of hydroxyapatite, but the 
existing processes to adhere HA to the three-dimensional nature of the pellicle limits the 
success of the resultant composite, and potential permeation of both cells and crystallites 
throughout the biomass. In this work, individual bacterial cellulose fibres were suspended 
in solution and used as a basis for HA crystal (Ca10(PO4)6(OH)2) growth, with the 
ultimate goal of producing growth factor-seeded hollow bone fibres for GBR. 
The BC was produced via Acetobacter xylinum (currently obtainable as Glucoacetobacter 
xylinus via ATCC), in 250 mL baffled flask increments, using a fructose- or maple syrup-
based media. The samples were left to grow in combination static/agitated culture, for 14 
days, before being homogenized and purified. The individual fibres were then treated 
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with orthophosphoric acid, in the presence of an aprotic solvent (dimethylformamide, 
DMF) and high temperature (136 °C), to phosphorylate the –OH functional groups in 
cellulose. Samples were then preconditioned with ionic calcium salt solution for 3 days. 
Simulated body fluid (SBF) containing several salts found in natural bone was then used 
to promote growth of the HA crystallites for two more weeks.  
In 14-day experiments, the resultant product was characterized on a semi-daily basis via 
Energy Dispersive X-ray Spectroscopy (EDX), Scanning Electron Microscopy (SEM), 
and Fourier Transform Infrared Spectroscopy (FTIR). EDX confirmed the presence of 
several mineral elements naturally occurring in bone, whilst FTIR confirmed the presence 
of phosphate groups. SEMs were used for qualitative and dimensional analysis. As a final 
characterization, X-ray Diffraction (XRD) was employed to quantitatively assess the 
crystallinity of the hydroxyapatite powders. The final molar Ca/P ratio of the pure 
hydroxyapatite was found to be as high as 1.51±0.22, which encompasses the standard 
ratio for hydroxyapatite of 1.67, although the fibre composites could only ascertain a 
1.45±0.92 ratio.  
The current study ultimately intends to further research into specific materials for the 
space-forming component of most guided bone regeneration solutions. To accomplish 
this, the nanometre-scaled bacterial cellulose fibre was utilized as a backbone for 
crystalline hydroxyapatite growth. The composite was characterized in its variety of pre-
treatment methods, and by means of its capability to nucleate the crystalline HA material. 
Similarly, the procedure was scrutinized in both the quality of the resultant composite, 
and the distribution of crystallites within the surrounding organic matrix.  
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1.2 Thesis Objectives 
 
1. To explore the functionality of bacterial cellulose, obtained via static and agitated 
cultures in the presence of different sugars (fructose, glucose/sucrose from maple 
syrup, etc.). 
2. To both produce and develop phosphorylated bacterial cellulose for the ultimate 
goal of application in guided bone regeneration therapies, using phosphorylation 
techniques. 
3. To grow significant amounts of calcium phosphates, ideally pure hydroxyapatite 
(Ca10(PO4)6(OH)2), on the surface of nanometre-scaled bacterial cellulose fibres, 
via pre-treatment and subsequent immersion in SBF. 
4. To characterize said composite fibres via Fourier Transform Infrared 
Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), Energy Dispersive 
X-ray Spectroscopy (EDX) and X-ray Diffraction (XRD) techniques. 
5. To evaluate differences in the samples formed as pellicles versus those formed 
and dispersed as individual fibres. In addition, to evaluate the differences in 
calcium pre-treatments as theorized by Kokubo [8]. 
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Chapter Two 
2.0 Background and Literature Review 
2.1 Tissue Engineering of Bone 
 
The reconstruction of skeletal deficiencies has presented a significant challenge to the 
medical community for decades. The repairable defects in question often occur 
specifically in the facial maxima as a result of trauma, surgery, tumour excision, infection 
or a variety of arthritic complications[9]. The major encumbrance to the widely-accepted 
procedures of rebuilding bone is the pervasion of the wound site via the rapid expansion 
of soft tissue material. In the oral cavity, this in-growth is particularly worrisome as the 
fibroblasts have experimentally been found to both inhibit the osteogenic properties and 
structure of the native material and the differentiation of the bone cells, leading to a 
substantially weak jaw line. Similarly, the atrophy that often surrounds the wound sites 
prevents the anchoring of prostheses or similar techniques of reconstruction[10]. 
To this end, numerous technologies have evolved to help in localized bone tissue growth. 
The most common method of this reconstruction is the harvesting and implementation of 
autogenous bone from another site on the patient for grafting purposes. This procedure, 
whilst ensuring the compatibility of the surgery for each individual case, results in higher 
operative costs and intensive surgical recovery, as well as potential for the donor site to 
become morbid or otherwise infected[11, 12].   
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Alternatively, an allogeneic or xenogeneic implant may be chosen, although these options 
are similarly fallible. First, considerations must be made as to whether or not to 
demineralise the implant. In the case of non-demineralised grafts, research has shown that 
an extremely low quantity of immediate osteoinduction occurs, largely attributable to a 
lack of adequate permeation of the requisite bone morphogenetic proteins (BMPs) and 
cells[12, 13]. Demineralised matrices find themselves to have similar problems. Although 
they have the potential to stimulate relatively significant amounts of initial 
osteoinduction, harsh treatments are necessary in order to both minimize the non-organic, 
crystalline component and subsequently sterilize the implant. These techniques result in a 
large variability in success rates, owing to partial hindrance of compression strength and 
structure of the scaffold, and leading ultimately to a significant (~10%) reduction in 
requisite bone salts[14, 15]. In addition, depending on the means used for sterilization 
purposes (glutaraldehyde, formaldehyde, ethylene oxide, irradiation), long-term 
osteoinduction may be compromised by potential cytotoxicity[16]. 
During the past two decades, however, industrially-produced hydroxyapatite has received 
the gross majority of attention as a substitute for techniques involving bone 
reconstruction. In this way, the open wound could be supplemented with a quasi-
amorphous, osteoconductive coating material that can be marginally adjusted to fit its 
surroundings. Similarly, within this time frame, the discovery of a new technique known 
as Guided Tissue (or Bone) Regeneration capitulated to the demand for a means of 
repairing tissue damaged by inflammatory periodontal disease. In a series of animal 
studies, several aspects of this technique were examined, resulting in wide acceptance of 
its legitimacy[17]. The addition of the membrane to the open wound site provided a 
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physical barrier to the effect of excluding non-desirable tissue cells (fibroblasts) from 
populating the area whilst simultaneously favouring the proliferation of requisite bone 
cells (osteoblasts and osteocytes). The membrane also had the added effect of 
necessitating space between the inner surface of the implant and the cavity, enabling 
room for further tissue growth. The above aspects – the hydroxyapatite powders and 
semi-permeable membranes – were mutually beneficial; the adjustability of the powders 
and the segregating properties of the membranes were found to be quite complimentary. 
 
2.2 Bone Biology and Physiology 
 
Bone is a composite material made up of two major components; an organic phase, 
predominated by collagen (Types I and II) and an inorganic phase made up of calcium 
phosphates, carbonates, and fluorides with a smattering of magnesium salts. Collagen, in 
the case of bone tissue, is a protein with good durability and a compounded structure, 
leading to a significantly high tensile strength (in excess of 140 MPa, for a single fibre, in 
the longitudinal direction)[18], and providing a secure place for the nucleation of the 
inorganic bone phase. In addition, collagen fibrils are osteoconductive to cell attachment.  
The materials comprising the inorganic phase are often collectively combined into a 
homogeneous mineral form known as apatite. The most abundant form of said apatite is 
hydroxyapatite; a compound with a strict stoichiometric formula of Ca10(PO4)6(OH)2. 
Apatites, in general, are found to be highly-crystalline minerals with a ceramic-like 
molecular structure, leading to higher compression strength and, due to the stoichiometry, 
play an important role in regulation of the body’s natural pH levels. It is the combination 
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of these above biomaterials, in an alternating structure of nano-scaled crystallites and 
coiled proteins, which provides the hardness and rigidity of bone. In terms of weight 
percentage, on average, the inorganic content is about 65%; the organic component and 
water makes up the remaining 35% of non-cellular bone weight[9]. 
On a nano-scale basis, bone is visually defined by the typical banding and fibril patterns 
of collagen. The collagen fibril, itself, a combination of three or more individual strands 
of collagen woven together in a gamma-helical pattern, lies in a collinear arrangement, 
with the hydroxyapatitic crystals capping the terminal ends (See Figure 2.2.1). These 
fibrils lie overlapping each other and are approximately 300 nm long with an end spacing 
of approximately 67 nm. The hydroxyapatite crystals, in turn, are even smaller (50 nm 
along its longest axis[19]), filling the 67 nm interim spaces between ends of fibrils, and 
forming a composite ‘cement’, which effectively binds the structure together. It is this 
ideal alternating spacing that produces the categorical banding pattern observable in 
transmission electron microscope (TEM) and atomic force microscope (AFM) images of 
bone. Fibrils group themselves together in bundles (collectively referred to as the  
collagen fibre) of 40-50 nm in diameter[20].  
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Figure 2.2.1: Bone microstructure, showing individual collagen fibril (left), a 
collagen fibre (centre), and the terminal end spacing of collagen, with 
hydroxyapatite crystals (right). 
 
The skeleton of a typical adult is perpetually in a dynamic state of being broken down 
and reformed by the coordinated actions of bone cells. These cells are responsible for the 
maintenance and repair of the tissue, which is central to the structural support, health and 
metabolism of the human body.  
The microstructure of bone contains a wide array of vascular networks and nerves, 
connected via horizontal spaces known as Volkmann canals. Larger bones in the body are 
made up of two distinct types of osteal tissue; a dense, cortical bone and a spongy, 
cancellous (or trabecular) bone. In figure 2.2.2, this distinction is emphasized with 
cortical tissues, in a solid colour, surrounding the trabecular tissue, with its distinctive 
1.5 nm 
(50 x 3 nm, 
approx.) 
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honeycombed structure. The cortical bone (a) exists mostly on the external ‘surfaces’ of 
the osteal tissue; in contrast, the cancellous bone is present internally, in the cuboidal/flat 
bones or in the terminal ends of long bones, as a space-saving device, ultimately existing 
to minimize the bone weight. In both cases, bone is vascularised by blood vessels (b) 
extending from a membranous, supporting tissue known as the periosteum (c) or through 
the Volkmann canals/Haversian system. In addition, the interior of most long bones 
contain an area of completely non-mineralized space known as the medullary cavity 
(shown as a darker area in the left figure). This space is filled with marrow; a tissue 
consisting of blood vessels, adipose tissue, nerves and other varied cell types/progenitors 
whose principal purpose is to generate the necessary cells present in blood and bone, as 
well as furthering existing vascularisation. The combination of osteal tissue and 
supporting tissue allows for a material in which maximal strength is achieved with 
minimal mass, and hence, all material substitutes must cater to both the structural and 
biological necessities. 
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Figure 2.2.2: Bone physiology. On a microscopic scale, the bone is further comprised 
of an interwoven network of osteal tissue surrounding Haversian canals (osteons) 
(a), blood vessels/capillaries (b), and bone cells (osteocytes) (c), as well as the 
aforementioned periosteum (d).  
 
The main types of cells associated with the metabolism and physiology of bone are 
osteoblasts, osteocytes and osteoclasts.  
Osteoblasts are the primary builders of bone. Their purpose is to produce proteins of the 
bone matrix; collagen and other non-structural proteins (such as differentiation markers) 
necessary to the tissue. Osteoblasts actively lay down successive concentric circles of 
bone within the inner walls of a cavity, creating osteons – the fundamental, cylindrical, 
structural unit of compact bone. This action continues until new bone encroaches on the 
blood vessels or nerves running down the length of the bone, ultimately resulting in what 
is referred to as the Haversian system. In addition to providing the matrix for the 
a) 
b) 
c) 
d) 
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mineralization of bone tissue, during osteogenesis, osteoblasts take on the role of 
secreting growth factors (including, but not limited to, Transforming Growth Factor 
(TGF-β), Insulin-like Growth Factor (IGF), Platelet Derived Growth Factor (PDGF), and 
Bone Morphogenetic Proteins (BMPs)[21, 22] to promote the influx of new bone cells. 
For a material to be deemed adequate for bone tissue engineering, these cells are of the 
utmost importance; the osteoblasts must be able to interact with, and adhere to, the 
surrounding scaffold matrix. 
Once osteoblasts become embedded in the bone matrix, they develop more dendritic 
structures and become osteocytes. These are the most abundant bone cells, 
communicating to one another via the existing canal system. The change in cell 
morphology results in cytoplasmic extensions of their cell membrane, which now create a 
direct continuity between the bloodstream and the remaining bone cells. This allows for 
the exchange of metabolic and biochemical transmissions, and to direct the further 
growth of underdeveloped woven bone[23]. 
Osteoclasts, on the other hand, are exclusively responsible for bone resorption; they 
appear as large, multi-nucleated, giant cells with several villi along one side. This side, 
referred to as the ruffled border, secretes the proteolytic enzymes and acids necessary to 
break down bone tissue - resorbing it - and releasing requisite ionic calcium, carbonates 
and phosphates back into the bloodstream. This continues for up to 3 weeks, during 
which the osteoclast can bore a hole several millimetres long, and after which the cell 
itself is degraded back into resorbable products[24]. This cavity is then seeded with new 
osteoblasts, and the cycle begins again. 
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It is this constant state of flux, bone growth, and resorption, provided by the bone cells, 
that allows the human body to maintain the structural integrity of bone. In addition, as the 
calcium and phosphate present in bone is also necessary to the regulation of the body’s 
natural pH balance, conduction of musculature, electrical impulses and metabolic state, 
the continuous breakdown and rebuilding of bony tissue is a necessary procedure in 
preventing disease and general health. As such, maintenance of diseased or otherwise 
compromised bone (via implants or tissue engineering techniques) is a necessary process 
to keep existing tissue from degrading uncontrollably, or otherwise becoming infected. 
Furthermore, for techniques of bone regeneration to be considered effective, the resultant 
process must kowtow to the above aspects of the bone physiology, cells and 
microstructure.  
 
2.3 Guided Bone Regeneration 
 
Guided Bone Regeneration (also known as GBR or Guided Tissue Regeneration) is a 
technique by which a surgeon artificially encourages re-growth of a lost portion of osteal 
tissue via a filler substrate and a membrane. The composition of this substrate is 
important as the material must be biocompatible and should preferably allow for 
proliferation of ‘bone-matrix producing’ osteoblasts. In the case of the filler, the required 
biomaterial must be requisitely fine enough and porous so that the aforementioned cells 
can affect their environment allowing the expansion of the extracellular matrix into the 
cavity. As such, the filler material is often composed of a porous hydroxyapatite powder, 
with grains ranging from 250-1000 µm[9]. As a corollary to this, the material is more 
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often than not covered by a barrier of sorts; this is done in order to simultaneously 
prevent unwanted migration of the filler into the surrounding tissue, the soft tissue into 
the cavity, and the collapse of the attempted remodel. The currently employed barrier 
membrane is usually composed of a non-resorbable compound such as expanded 
polytetrafluoroethylene (e-PTFE) or titanium foils. Reasoning behind the use of these 
particular materials is that their known biocompatibility will simultaneously eliminate the 
contamination of the wound by migrating soft tissue cells (the pericutaneous flap is 
sutured over top of the membrane) and, similarly, prevent unexpected osteoinduction of 
bone cells into the surrounding tissue. Non-resorbable membranes, in particular, are often 
used, as they are more likely to hold up under the biological stresses of the wound 
reconstruction site. Unfortunately, this also results in two unwanted consequences; the 
same membrane that must be occlusive to cells must also be simultaneously permeable to 
oxygen and gases, nutrients, etc. In addition, the membrane must, after a given time of 
regeneration, be removed from the wound site, causing excess discomfort and further 
anguish to the patient.  
As is shown in figure 2.3.1, the site of the technique must be (a) cut open in order to 
expose the cavity. A barrier (b) is inserted, providing cell occlusion, whilst also 
containing the filler material (textured). The barrier also allows for the proliferating bone 
cells to enter and reform the matrix, as indicated by the arrow (c). 
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Figure 2.3.1: Guided bone regeneration summary, showing the eroded bone site (a), 
the surgery and implantation of matrix/membrane (b), and the migration of cells to 
the wound site post-surgery (c). 
 
Whilst this technique is certainly applicable to all types of bone, the particular nature of 
the wound cavity and the prerequisites of the site environment lend themselves well to 
applications in dentistry. Quite often, in the case of root canals, the jaw bone must be 
excavated in order to set the metal supports in place[25]. At the time of this writing, 
guided tissue regeneration has been shown to further promote the growth of the dental 
bone into the space and threading between the implant screws and the existing 
mandible[26], more so than typical osteointegration. That said however, guided bone 
regeneration is not without its fallacies, largely inherent to the nature of the procedure. It 
fails to work successfully on vertical surfaces (little to no basis for filler attachment), 
large or single-walled defects (coverage of the wound site is difficult), or regeneration 
cavity 
periosteum 
surrounding 
bone 
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sites where the bone is not close to the surface (advanced trauma of subsequent 
procedures)[9].  
As such, there are several requirements that have to be made of the materials and the 
technique itself. The membrane barriers and ‘filler HA material’ must be used in tandem 
to simultaneously close the cavity, allow for vascularisation (have pores of adequate size 
and morphology), prevent dissolution of existing bone and stabilize the wound site[17]. 
Quite often, as discussed, membranes are also non-resorbable, requiring additional 
surgery. These principles are discussed in much further detail in section 2.3.2. 
This technique, in practice, can be atypically costly and ineffective in promoting cell 
migration and growth, despite attempts to increase induction of bone cells into the area. 
Nevertheless, several commercially available products have been introduced to the 
market, attempting to secure a niche. Some examples of these products include Bio-
Oss®, OsteoGraf®, and PepGen®, the latter of which substitutes amino acid residues 
(RGD sequences) in an attempt to draw more significant osteoblast attachment[9]. 
 
2.3.1 Brief Historical Background of Guided Bone Regeneration (GBR) 
The first indication of physically sealing off an anatomic site for improved healing and 
tissue regeneration stems from the mid-1950s. Campbell and Bassett in 1956[27], and 
Hurley et al. in 1959[28] actually used cellulotic material for nerve and tendon 
regeneration, respectively. It wasn’t long before this technology extended into the realm 
of bone regeneration. Brånemark and his colleagues[29, 30], in 1969, first proposed the 
idea of implant dentistry via the use of pure titanium implants in dental surgery. 
17 
 
 
Ironically, this came from an unforeseen incident in which the proposed titanium became 
largely integrated into natural canine bone tissue, and existing bone began anchoring 
itself to the interim spaces between implant and tissue.  
In the subsequent years, several authors continued the landmark work, culminating with 
the discovery of Page et al. in 1976[31], whereby a direct bone-to-implant contact of a 
non-submerged titanium implant promoted what the authors termed osteointegration. 
Whilst this actually proved the ability of non-native materials to stimulate the subsistence 
of bone and the capability to manipulate surrounding tissues, it in no way actually 
suggested the induction of bone growth or osteogenesis of the material. As such, two 
seemingly occlusive branches of the research were integrated with an experimental 
evaluation of the healing process of mandibular defects in rabbits. This work, pioneered 
by Kahnberg in 1980[11], used Teflon leafs to prevent in-growth of scar tissue, whilst 
maintaining a titanium implant surface. From there, the leap to expanded 
polytetrafluoroethylene (e-PTFE), and the addition of osteopromoting filler materials 
(such as autogenous bone chips) is easy to see. By the time of Dahlin et al. in 1989[32], 
the fundamental theories of GBR as a legitimate means of bone growth were well 
established. Although this employed titanium structures in the tibiae of rats and rabbits, 
the work nonetheless pioneered what was to be a large and widely recognized field. 
 
2.3.2 Principles of Guided Bone Regeneration 
Guided bone regeneration is used fairly often in implant and reparative dentistry. The 
requirements of the wound site, stipulated by Dahlin[17], for the successful predilection 
of bone growth via GBR are as follows: 
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• Source of Osteogenic Cells. Viable bone must be present in the surrounding 
tissues. 
• Existing Vascularity. More often than not, this comes from existing bone 
marrow, Volkmann canals, and intermediate lacunae of existing bone. 
• Mechanical Stability. The repair site should not collapse upon itself. 
• Adequate Spacing. This is usually generated by a temporary filler material of 
sufficient porosity. 
• Occlusion of Soft Connective Tissue, such as periosteum, from the site of bone 
growth (assisted via the use of membranes). 
 
In addition, the materials of the filler and membrane themselves must have further 
additional requirements[33]: 
• Biocompatibility – All immunological reactions must be accounted for and, in the 
course of preparation of the filler/membrane, must be adequately tested. This may 
or may not include the lyophilisation and complete sterilization of the material.  
• Functionality – Diffusion of nutrients and oxygen into the tissue must be 
maintained.  
• Tissue adhesion and integration – Often, the tissue must grow into the thickness 
of the filler, and even partially into the membrane, but not through it. Should 
periosteal tissue grow through the porous exterior surface of the membrane, this 
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has the potential to result in an aptly named "flap-membrane complex", which 
would seal the membrane in place and prevent apical re-growth of epithelial soft 
tissue cells, allowing exposure to bacterial infection. 
• Structural stability – The filler and membrane, as a composite treatment, must be 
able to hold up under the pressure of the soft tissue, and often, due to the 
implantation procedure itself, the weight of the suture pressing down upon it.  
• Adaptability – This is more of a commercial requirement, and more applicable to 
the membrane, however, the chosen material must be able to encompass the 
wound site without resulting in folds, protrusions or edges. This is done to ensure 
complete site occlusion, and is usually accomplished by cutting membranes to fit 
precisely and adding a saline solution (or the patient’s blood/plasma) to stretch 
and soften both the membrane and filler first. 
 
2.4 Material Selection 
 
2.4.1 Cellulose 
Over 160 years ago, Anselme Payen isolated and purified cellulose from green 
plants[34]. Since then, cellulose has held an important place in the biomedical and 
industrial fields, being one of the most abundant polysaccharides on Earth. For years, the 
material was lauded for its high degrees of biocompatibility, high tensile strength, and a 
Young’s modulus for individual fibres (35-90 nm thick) of 78 ± 17 GPa[35], although 
later papers have placed the value for the fibrils as high as 138 GPa[36, 37]. Coupled 
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with a tensile strength of at least 2 GPa, this effectively makes the strength of the fibres 
themselves comparable to that of aramid fibres. In addition, the substance has the added 
benefits of widespread availability and significant crystallinity. These benefits have oft 
been tempered by the complications derived in purification; the cellulose found in plant 
matter is contaminated with proteins, lignin and uncontrolled branching of the main 
chain, resulting in what is referred to as hemi-cellulose. Cellulose is nevertheless 
traditionally produced in industry from fibrous plant matter, as availability and access 
outweighs the costs of purification via acid hydrolysis and separation.  
 
 
Figure 2.4.1.1: The repeating unit of pure cellulose, showing glucose monomer units 
and the β (1→4) linkages. 
 
Bacterial cellulose, on the other hand, provides an advantage over the conventional 
material, as the bacterial culture can be directed into the production of cellulose chains 
exclusively, yielding the purest form of the polymer (containing no lignin or 
hemicelluloses). Experimentally, it was found that BC also provided the benefit of finer 
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fibrils of the material, suitable for use in composites. In literature, BC is reported as being 
produced with high crystallinity, fine microstructure (25-50 nm in diameter) and long 
fibre length (~5 µm)[1]. Bacterial cellulose has also been found to have a larger degree of 
polymerization in comparison to that of wood pulp cellulose. The average residue 
monomers of glucose per molecule of bacterial cellulose is around 6000 in acidic shaken 
culture (see Figure 2.4.1.1). Note that plant cellulose glucose residues can occasionally 
approach 15000[38] for a single molecule although, these values fail to take into account 
the presence of the hemi-cellulose branching.  
BC was first discovered and isolated by A.J. Brown in 1886[1], from the acetic 
fermentation of fruits and vegetables in various states of decay. Although he was the first 
to identify the culture of Acetobacter xylinum (also known as Acetobacter xylinus or 
Glucoacetobacter xylinus), his work proved premonitory as people in the Philippines 
have often used the material (and its bacterial progenitor) in the manufacturing of ‘nata-
de-coco’, a coconut-flavoured snack with the consistency of gelatine. Based upon this 
groundbreaking work, the field soon exploded, including, at the time of this printing, 
applications in fields of separation membranes, speakers, paper-making, burn recovery 
and wound dressings[6, 39, 40]. Concurrently with this research, the use of the bacterial 
cellulose as an additive in the field of heart valve or vein replacement has come to 
fruition[2]. 
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2.4.2 Hydroxyapatite 
In a similar manner, the major inorganic constituent of bone, hydroxyapatite, has often 
been greatly acknowledged as an applicable and popular material for research. Formed in 
the body, and known to be a commonly-occurring synthesis product of calcium and 
phosphates, non-stoichiometric hydroxyapatites (or occasionally “hydroxyl-apatites”) are 
largely responsible for the characteristic sturdiness of bone. Whereas the collagenous 
component of the bone largely defines the structural tensile strength, the hexagonal 
crystal structure of hydroxyapatite, coupled with the bonding between ionic groups leads 
to a material that, similar to many ceramics, boasts extremely high compression strength.  
 
              
 
Figure 2.4.2.1: Crystal structure of pure hydroxyapatite [Ca10(PO4)6(OH)2] as 
projected down the c-axis. Note the overlap of two pairs of columnar calcium (Ca1, 
Ca2, Ca3 and Ca4) on the far left and right, and the paired hydroxide groups (OH1 
and OH2) in the centre. 
 
Ca1 
Ca2 
OH2 
OH1 Ca4 
Ca3 
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Hydroxyapatite falls into a categorization scheme largely based upon its essential 
chemical elements. This places it under an umbrella group of materials known as apatites. 
As an apatite, comparisons can be drawn between HA and a wide array of substances 
with similar mechanical properties, such as tourmaline, beryl, limestone, chlorapatite, 
bromapatite, and fluoroapatite. In fact, the similarities are so great that, often, other 
members of this categorization scheme are found in smaller amounts within each natural 
HA deposit, collectively making up the bone salts. To this end, the generic form of all 
apatites is defined as being “a crystalline material with a composition of M10(XO4)6Y2” , 
in which M is a metal from Group II, X is either phosphorus or sulphur, and Y is a 
halogen, or similarly valent chemical compound[41].  
Within the limitations of this composition, hydroxyapatite, specifically, is characterized 
by its chemical formula, Ca10(PO4)6(OH)2, and its distinctive ‘Ca-to-P’ molar ratio of 
1.67. This precise ratio also identifies the substance as differing from most other calcium 
phosphates such as tricalcium phosphate (TCP) and octacalcium phosphate (OCP), both 
of which, however, are known precursors. In terms of chemical structure, HA consists of 
a ring of six phosphate ions, bounding a similar ring of six calcium ions (see figure 
2.4.2.1). The entire structure surrounds the overlapping hydroxide ions in the center of 
both these rings. A quartet of calcium ions, in two separate overlapping sites 
(occasionally referred to in literature as being ‘columnar calcium’), completes the crystal 
structure. The morphology of the HA is therefore hexagonal in nature, and takes on the 
appearance of spiny to platy crystals (or ‘squama’) with a Mohs hardness of about five. 
The crystals themselves have six (100) faces, therefore explaining the interfacial 
properties and potential derivation from a similar structure found in precursors such as 
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octacalcium phosphate[42]. It is qualitatively described as having a waxy, slightly off-
white appearance, with a space group of P63/M and lattice parameters of a = 9.424 Å, b = 
9.424 Å and c = 6.879 Å (γ = 120°, so as to maintain the hexagonal pattern)[43]. 
Biological apatite is found in its highest concentrations in nature in cortical bone, or in 
that of the teeth (dentine, enamel, etc.), of most species of bird, animal and fish. This 
inorganic material accounts for approximately 55%, 70% and 96% of the weight of 
average human bone, dentine and enamel, respectively[41], with the remaining 
constituents being cell mass, collagen and other components of the extracellular matrix, 
not to mention a significant proportion of water.  
Non-biological hydroxyapatite, in turn, is often produced ex vivo as a high temperature 
(>900°C) precipitation reaction between orthophosphoric acid and calcium salts. 
Nevertheless, in a quest to obtain a more economically sound means of producing the 
apatite, several methodologies have recently come to the forefront, such as pyrolysis[44], 
sol-gel synthesis[44] and biomimetic synthesis via Simulated Body Fluid (SBF)[43]. 
Kokubo first proposed the latter method in which he foresaw applications to the 
biomedical industry. As it stands presently, the biomaterial itself, obtained via this 
biomimetic route, has found niches in dental implantations, pericutaneous and 
periodontal devices/treatments, and spinal surgery, but to name but a few[32].  
It has long been discussed that the integration of both calcium and phosphate ions into a 
matrix of hydroxyapatite takes place over several determinate intermediates. The 
discovery of the mineral itself and the role it played in bone tissues has been known since 
the late 1920’s[42], however, it took several more decades before the process by which 
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this component materializes was even considered, let alone quantified. In several 
landmark papers published by W.E. Brown around 1962[45, 46], the necessary evolution 
of “lower quality” calcium phosphates such as TCP (Ca3(PO4)2) and OCP 
(Ca8(HPO4)2(PO4)4) into HA became evident, and the nature of the long, spindly, needle-
shaped, amorphous hydroxyapatites observed in SEMs and the like became more and 
more well-known. As the bone requires small amounts of disorganization in its crystals 
(through the presence of carbonates, other apatites, and the aforementioned calcium 
phosphate precursors), it is clear to see that, although the term ‘HA’ is used 
interchangeably here in this document, variability of things such as Ca/P ratios and 
crystallinity is quite common in nature. The goal to ascertain idealistic stoichiometry, in 
this respect, is therefore merely for posterity’s sake. 
 
2.5 Biomimetically Synthesized Composites via Simulated Body Fluid 
 
By virtue of its definition, the success of a biomimetic process largely depends on the 
quality of the pre-existing materials as well as the success of the natural process it is 
imitating. In the case of hydroxyapatite, this effects itself in the form of a solution known 
as SBF or simulated body fluid. As discussed previously, Kokubo et al.[8] first identified 
the usefulness of such a biological process to introduce hydroxyapatite crystals to 
surfaces and fibres, from metals to ceramics. The necessity behind an adequate 
biomimetic system in this particular case was driven by existing methods of apatite 
coating requiring a heat treatment step, creating layers of HA that were different in 
structure to their bone counterparts, not to mention the possibility of compromising the 
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foundation material. On the basis of a previous experiment, which included silicate glass 
and excess Ca ions, the authors proposed that the same apatite coating could be formed 
on the surface of non-bioactive materials placed in the vicinity of a SiO2 glass ceramic 
plate. The glass was formed using CaO, MgO, P2O5 and CaF2, in addition to silicon 
dioxide, in order to promote the precipitation of HA. The glass was then milled and 
polished. These glass discs, together with the samples for HA growth, were placed into a 
carefully prepared solution of bone salts. This fluid became the true champion of this 
experiment. It contained ratios of salts and a buffer – tris(hydroxymethyl)aminomethane 
– otherwise known as TRIS, formulated in order to mimic the characteristic ion 
concentrations of human blood plasma.  Substrates used included commercially-fused 
silica glass, sintered alumina ceramics, slide glass, sintered yttria-stabilized zirconia 
ceramic, stainless steel (316), various titanium alloys, and several polymers (including 
poly(methylmethacrylate) and polyethylene). All samples were cut to the appropriate size 
and then left in 36.5°C solution with the aforementioned nucleating glass for 7 days. 
XRD and SEM characterization experiments showed significant apatite crystal growth on 
the sample surface. The FTIR experiments also confirmed this hypothesis, adding that the 
bands around 1400 cm-1 indicate not only HA, but HA with an appropriate amount of 
carbonate ions, similar to that found in bone. All the samples appeared to have a 
significant coverage of the apatite as well; the biomimetic growth was not limited to 
substrate type or morphology. The experimenters also quantified the mechanism of 
hydroxyapatite growth; first, the silicate ions in the prepared glass were adsorbed onto the 
surface of the scaffold. Second, the calcium and phosphate nucleation occurs on the 
adsorbed silicate ions; and third, the apatite nuclei grow from a reaction with SBF, which 
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is supersaturated with respect to apatite (HA is only weakly soluble). This concluded that 
the stability of a substrate in SBF will solely determine its ability to grow HA adequately. 
As long as the scaffold materials do not dissolve into apatite inhibitors, and the solution 
maintains its supersaturation, the bone-like material was theorized to continue to grow.  
Lickorish et al.[47] proposed a typical collagen-based scaffold for bone graft substitutes 
using a similar biomimetic process. The scaffold, of significantly high porosity, required 
a glutaraldehyde vapour to stabilize and cross-link, which, as it is cytotoxic in high 
enough concentrations, significantly calls into question the viability of a biocompatible 
product. The collagen was derived from bovine dermal tissue and moulded before being 
freeze-dried. The resultant discs were then cross-linked using glutaraldehyde vapour. The 
scaffolds were allowed to grow in a nucleation solution of NaCl, NaHCO3, KCl, 
K2HPO4, MgCl2 6H2O, CaCl2, and Na2SO4, buffered with TRIS, for an excess of four 
days before being removed from solution, washed, and placed in SBF for an additional 14 
days, with daily replenishment of solution. The resultant samples were then characterized 
via SEM, XRD and EDX, concurrently with cell culture experiments to assess 
cytotoxicity and cell attachment.  
The resulting analysis of these samples shows a scaffold with a variety of thermal 
stabilities based on degree of cross-linking. The samples were also characterized as 
having a honeycomb surface, comprised of collagen, along with spherical beads/clusters 
of nano-crystalline HA. The samples also, depending on the degree of exposure to the 
nucleation solution and SBF, led to some thicker coats of HA, which might, as the author 
admits, obscure the natural porosity. The Ca/P molar ratios of scaffolds were found to be 
well within the expected limits for HA (approximately 1.61 ± 0.23).  
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Cell culture work using L-929 fibroblasts and rabbit periosteal cells on the scaffolds 
showed a relatively cytocompatible product, with decent proliferation up until the 48th 
hour. At this point the proliferation rate seemed to trail off in the HA-seeded samples (in 
comparison to the pure collagenous controls). Nevertheless, the cell morphology was 
qualitatively considered to have developed as normal. 
Oliveira et al.[48] suggested the application of Kokubo’s solution to a then uncommonly 
utilized polymer in the form of starch. The main difference in the proposed procedure 
was to add a sodium silicate step into the process to effectively augment the necessary 
nucleation. The backbone for HA growth was obtained as a pre-existing composite blend 
of starch and ethylene vinyl alcohol, and the samples required microwave baking to sinter 
and form the necessary architectures.  
Once the samples were obtained, they still needed to have the above sodium silicate pre-
treatment. This was performed using a commercially available silica gel (Na2SiO3•H2O). 
Viscosity had to be proportionally adjusted so as to assure permeation of the gel into the 
fibres as well as maintain the homogeneous and thin layer of sodium silicate gel thought 
necessary for impregnation. The authors predicted that, with the –OH groups already on 
the surface, and the natural hydrophilicity of starch, the apatite layer would be nucleated 
effectively.  
Resultant composites had a very rough appearance, showing a cohesive layer of apatite 
formation, but with fragmentation due to polymer swelling. This was compounded with 
the presence of several alkali metals (Na, Mg and K) that displaced the Ca in the apatite 
formation, leading to a lower Ca/P molar ratio than that described elsewhere (1.4 to 1.5, 
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versus 1.67 expected). This still falls within the range of bone calcium phosphates, 
lending itself more towards tricalcium phosphate or octacalcium phosphate than HA. 
XRD confirms this by showing a poorly crystalline HA formation. 
Fricain et al.[49] showed promise in their use of cellulose phosphates (otherwise known 
as phosphorylated cellulose) as biomaterials as well. The premise of their work was not 
to quantify or justify yields of the material, but rather to ascertain the in vivo 
biocompatibility of the resultant composites. The motivation behind this experimentation 
was the sudden prevalence of non-phosphorylated cellulose as a biomaterial due to its 
promotion of cell attachment and proliferation, yet waning mineralization in terms of 
simulated bone conditions. The authors predicted that the presence of phosphorylated 
cellulose might beget a better chance of nucleating calcium phosphate growth, in 
controlled conditions, so as not to cause the decrease of the inherent biocompatibility of 
the cellulose scaffold.  
To produce these results, the scaffold of choice was reconstituted cellulose machined into 
a disc shape, and phosphorylated in n-hexanol (C6H13OH). The modified material was 
then dried at room temperature before being pre-treated in CaCl2 solution and inserted 
into the femoral condyles of four month-old white rabbits. The pre-treatment step also 
allowed for the samples to be moist enough to prevent excess swelling in vivo. The 
samples were retrieved after two and six months, fixed in formalin (for histological 
purposes), and characterized. The extracted cellulose phosphates showed promise in that 
they were coated by significant amounts of periosteum-like tissue and seemed to be well 
integrated into the bone structure. Multinucleated ‘giant’ cells were also observed, similar 
to those found in natural bone as osteoclasts. The phosphorylated cellulose samples had 
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an added advantage of adherence to the implant site and partial/total incorporation into 
the surrounding bone tissues. The SEM and concurrent EDX results confirmed the 
presence of HA with significantly low Ca/P molar ratio (1.06), although the needle-like 
protrusions that are indicative of calcium phosphate growth were present. 
Svensson et al.[50] proposed the use of bacterial cellulose in the growth of cartilage, a 
tissue known to be closely related to that of bone. As the native mechanical properties of 
cartilage are very specific and hard to replicate, the existence of legitimate tissue 
engineered constructs are few and far between. Bacterial cellulose was used, in both a 
native and chemically-modified form, as a scaffold for the growth of chondrocytes, or 
cartilage cells. The material properties of the cellulose lend themselves particularly well 
to the natural collagen-based extracellular matrix, as does the porosity of the nano-scaled 
fibres. The bacterial cellulose was grown in the form of pellicle disks and purified before 
being phosphorylated in DMF and phosphoric acid. Samples were then rinsed and 
lyophilized before being seeded with primary bovine chondrocytes and incubated for up 
to 8 days. A concurrent cell study also used human articular cartilage cell lines.  
Resultant samples were characterized using SEM and confocal microscopy, as well as a 
mechanical analysis of the unseeded samples. The mechanical testing confirmed that the 
phosphorylation did not change the Young’s modulus or the ultimate tensile strength of 
the fibrous network to any significant degree. In addition, in testing, the Young’s 
modulus of the phosphorylated bacterial cellulose composite was found to be similar to 
that of the native articular cartilage.  
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Cell cultures on the various samples showed that, in the case of non-phosphorylated 
fibres, chondrocytes took on a relatively more spherical appearance, whereas, in the 
presence of phosphorylated BC (BC-PO4H2), the cells spread out, took on an extended 
morphology, and adhered more strongly to the surface. The viability and proliferation of 
cells in the phosphorylated samples occurred more readily and to a greater extent. 
Collagen (types I, IIA and IIB) expression was also noted in the secondary cell culture 
experiments with human articular cartilage cells. In addition, TEM analysis showed that 
the cells migrated partially into the pellicle scaffold. 
 
2.6 Bacterial Cellulose-Hydroxyapatite Composites 
 
Wan, et al.[6] first provided pioneering work in the field of hydroxyapatite-bacterial 
cellulose composites. In their paper, a basic procedure to procure these fibre composites 
was outlined, beginning with pellicles formed by Acetobacter xylinum, after seven days 
of growth. The pH was carefully monitored throughout, as it was during the NaOH 
purification of the resultant cellulose. The pellicle was then phosphorylated to initiate 
calcium phosphate precipitation. This was performed using 200 mL of 
dimethylformamide and 15 g of urea. As the solution was heated, a source of phosphate 
groups – 19 mL of 98% orthophosphoric acid – was added to the flask, along with excess 
DMF. The solution was allowed to remain this way for about one hour under a blanket of 
nitrogen gas. This served to add PO43- groups to the cellulose backbone and allowed for 
sites of HA growth. As evidenced in figure 2.6.1, the group proposed a replacement of 
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the –OH groups on the cellulose with the phosphate groups via their phosphorylation 
reaction. 
 
Figure 2.6.1: Proposed means of functional group replacement on bacterial cellulose 
backbone, as it pertains to the current experiment. 
 
Once phosphorylated, the cellulose pellicles were pre-treated with CaCl2 solution at 
37°C, before being mixed with Kokubo’s 1.5x SBF solution[8]. The pellicles were then 
allowed to grow HA crystals in incubation at 37 °C for 7 to 14 days. After this treatment 
in SBF, the calcium and phosphate groups were found to be further supplemented with 
those of magnesium, carbonate, sodium, hydroxide, potassium and chloride, all of which 
can be indicative of an apatitic coating. The results of this experiment show a surface that 
is rife with HA nano-crystallites. The characterization of the pellicles, using scanning 
electron microscopy (SEM), X-ray diffraction (XRD) and inductively coupled plasma 
atomic emission spectroscopy (ICP-AES) indicate a homogenous precipitation of the HA, 
as well as an abundance of carbonate-containing crystals, mimicking that of natural bone 
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apatites. The XRD analysis indicated that the HA was of significantly low crystallinity, 
however, the crystal sizes were on a nanometre scale. 
Wan et al., in a subsequent paper published in 2007[7], further extolled the virtues of 
using bacterial cellulose as a means for growth of hydroxyapatite crystals. The samples 
were prepared much as before, using bacterial cellulose pellicles grown for a period of 7 
days, a NaOH pre-treatment, and a surface modification via CaCl2. The viability of the 
phosphorylation step was questioned this time, however, as the experimenters used a non-
phosphorylated pellicle for a control. The samples were then left in SBF solution for 7 
and 14 days, to quantitatively compare the two degrees of growth. Resultant scaffolds 
were compared via scanning electron microscopy (SEM), transmission electron 
microscopy (TEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy 
(FTIR) and energy dispersive X-ray spectroscopy (EDX). 
As before, the samples were found to have significant amounts of hydroxyapatite growth, 
with crystallite sizes growing proportional to whether or not the sample was 
phosphorylated and the length of time grown in SBF. The interesting thing to note, 
however, was that the use of non-phosphorylated samples appeared to grow crystals as 
well; however, the clusters of crystals grouped together to form large spheres instead of 
even coatings on the fibres. In addition, the crystallites themselves had more amorphous 
regions. Also, the researchers questioned the legitimacy of the procedure when it came to 
growth of HA within the samples. The pellicles appeared to have a significant decrease in 
crystallite growth interior to the pellicle when it came to non-phosphorylated samples, 
implying that the growth of crystals was more of a physical deposition than in samples 
that were phosphorylated.  
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These same nano-composite scaffolds were used in subsequent papers in the investigation 
of proliferation/differentiation experiments with stromal cells [51]. In a series of 
experiments, the researchers replicated the procedures discussed above for producing 
BC-HA nano-composites, and then exposed said disks to a cell suspension of stromal 
cells obtained from human bone marrow (hBMSC). Cells were incubated in alpha 
minimal essential medium (α-MEM) for up to 132 hours (5.5 days) to ascertain cell 
viability and proliferation. 
SEMs revealed the morphology of the cells attached to the surface of the scaffolds. 
Although cross-sectional data was not provided, the cells on the surface appeared to 
tightly anchor themselves to the matrix using their pseudopodia. Proliferation was found 
to be similarly committal, although statistically significant growth was observed on plain 
bacterial cellulose controls as well, owing to its known biocompatibility. Alkaline 
phosphatase, osteopontin, osteocalcin, and bone sialoprotein expressions, all of which are 
key osteoblastic differentiation markers, were found in the scaffolds of both the control 
and the nano-composite. Activity was notably higher in the latter and on the topographic 
surfaces of the samples, as the pore sizes were found to be much smaller than the stromal 
cells. To this end, it was concluded that there exists a niche for substantial 
hydroxyapatite-bacterial cellulose nano-composites, especially in the fields of dentistry 
and orthopaedic oncology.  
Despite the apparent success of aforementioned works, there is yet a significant amount 
of research to be done. Even with arguable evidence to the contrary, there is means to 
suggest that the resultant hydroxyapatite is merely adhered to the surface of the cellulotic 
pellicle, and not consistent throughout. In addition, complete coverage of individual 
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fibres has not been extensively examined, merely composites of compressed or 
reconstituted fibres tested mainly for strength and viability.  
Similarly, the idyllic, albeit extensive, coating of the fibres necessitates a belief that the 
final product of this experimentation would be a hollow hydroxyapatite fibre which, after 
extensive pre-treatment, could be filled with growth factors and bone morphogenetic 
proteins of its own. This could ultimately result in the growth of the natural bone tissue 
on a substrate that was nano-scaled, three-dimensional (from the perspective of the cells), 
and easily malleable, with the added benefits of osteoinductive properties.  
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Chapter Three 
3.0 Materials and Methods 
3.1 General Procedure 
 
The impetus behind this study was to ultimately procure HA fibres for guided bone 
regeneration therapy, through a process illustrated in figure 3.1.1, below. The procedure 
by which this would theoretically be accomplished followed several succinct and 
determinable steps. First, the bacterial cellulose was to be obtained, using the bacteria 
Acetobacter xylinum (BPR 2001), utilizing a maple syrup-based media. The bacteria 
would be grown in a shaker incubator for a period of two weeks, at which point it would 
be washed and purified.  
Resultant cellulose was to be treated to replace the hydroxyl groups on the chain with 
phosphate groups using phosphoric acid. The phosphorylated cellulose would be 
subsequently pre-treated with calcium ions, displacing the acidic protons. After several 
days in an environment mimicking the temperature of the human body, the pre-treated 
cellulose would then be doused in simulated body fluid for two weeks, hopefully 
resulting in an even and uniform coating of hydroxyapatite on bacterial cellulose fibres. 
The composite material could then be treated with a cellulase enzyme, which would 
ultimately break down the cellulose fibres, and leave behind the shell of HA, now in a 
nanometre-scaled, fibre form. These fibres could consequently be seeded with several 
growth factors necessary to bone growth, such as bone morphogenetic proteins (BMPs), 
platelet-derived growth factors (PDGFs), insulin-like growth factors (IGFs) and/or their 
 analogues. At this point, the 
bone regeneration techniques, as they would fulfill the necessary requirements of 
structural integrity, mouldability
 
Figure 3.1.1: Flowchart for the production of hollow hydroxyapatite 
 
fibres would theoretically be sufficient for employment in 
, and biocompatibility. 
guided bone regeneration. 
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In practice, however, not all these steps could be completed for a variety of reasons to be 
discussed later. Only the BC-HA fibres were actually reproducible in vitro. Nevertheless, 
the biocompatible BC-HA fibres are also applicable as a filler material, with a significant 
degree of potential for further development. 
 
3.2 Stages of Bacterial Cellulose Growth 
3.2.1 Apparatus 
 
 
Figure 3.2.1.1: Continuous baffle flask growth of bacterial cellulose over the course 
of 14 days. Figure shows the development after 2 days (a), 3 days (b), 4 days (c), 7 
days (d) and 14 days (e). 
 
Above (Figure 3.2.1.1) is an image of the required apparatus for producing bacterial 
cellulose (a simple baffle flask and sample of the bacteria). In the first three images (a-c), 
the pellicle growth is observed pressing downward in the baffle flask. Subsequent images 
4 days3 days2 days
a) b) c) 
d) 
e) 
39 
 
 
highlight the pellicle after 7 days of incubation (d), and the BC growth, as a large mass, 
once the shaker was employed for an additional 7 days (e). 
 
3.2.2 Procedure 
The procedure for obtaining bacterial cellulose is derived from that of Joseph[1] and 
adapted by Guhados[35] and Zeng[52]. These sources were instrumental in proposing the 
specialized aqueous media for the re-growth of Acetobacter xylinum under static/shaken 
conditions as follows: 
 
Table 3.2.2.1: Reagents for Acetobacter xylinum growth medium 
Order of 
Addition Reagent 
Quantity 
Fructose-
based 
media (250 
mL) 
Fructose-
based 
media 
(per litre) 
Maple 
syrup-based 
media (250 
mL) 
1 Deionised H2O 250 mL 1 L 243.5 mL 
2 Maple Syrup - - 6.5 mL 
3 Fructose 5 g 20 g - 
4 (NH4)2SO4 0.825 g 3.32 g 0.825 g 
5 KH2PO4 0.25 g 1 g 0.25 g 
6 MgSO4•7H2O 0.0625 g 0.25 g 0.0625 g 
7 Trisodium Citrate 0.105 g 0.42 g 0.105 g 
8 Citric Acid 1.1 g 4.4 g 1.1 g 
9 Yeast Extract 10 g 40 g 10 g 
 
For a 250 mL sample, components 2 through 8 in the above table were dissolved, in 
order, in a 500 mL baffled shaker flask filled with 150 mL of the deionised water. 
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Assurances were made, each occasion, to dissolve the entirety of the previous component 
before the addition of the next.  
In a smaller flask (~125 mL), the yeast extract alone was dissipated in the remaining 100 
mL of DI water for several minutes, using a magnetic stirrer. Both flasks were then 
autoclaved at 121 °C and 20 psig for 15 minutes. After sterilization, the two flasks were 
mixed aseptically in a laminar hood. It was determined to be necessary to isolate these 
two flasks in order to prevent the degradation of the media via side reactions from 
autoclaving nitrogen with other components (such as the Maillard reaction).  
The flasks were then allowed to cool back down to room temperature overnight before 
seeding with sample of liquid culture. The optimum amount of sample was ascertained to 
be 6% v/v of liquid from a pre-cultured sample flask[52] – approximately 15 mL. In the 
case of re-growth from plates, first 5 mL of media was poured off into a sterile test tube 
and seeded with a colony from the agar plate before scaling up to the 250 mL flask. This 
was done in order to prevent shocking the bacterial culture. Samples were then kept in the 
shaker incubator at 27 °C for a minimum of 12 days, and as much as three weeks. If 
employing shaken cultures, 2-3 drops of Antifoam 289 were added to the flask before 
incubating. Growth of cellulose was found to work best if samples were allowed to sit in 
static culture for a period of 7 days before shaking was started (140 RPM), as it is thought 
to be conducive to the growth kinetics[1].  
In order to produce pellicles, samples were left undisturbed in static culture. A 1 cm thick 
pellicle was achievable after approximately one week. In both shaken and unshaken 
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conditions, growth of cellulose was visible after 2-3 days (4-5 days if re-growing from 
plate culture). 
Once obtained, the pellicles were sent through a rigorous treatment and purification step.  
The flasks were autoclaved once again to arrest the growth of the bacteria. The flasks 
were allowed to cool, before being homogenized via a laboratory blender for a period of 
no longer than 40 seconds. This was done to break up the cellulose pellicle and free the 
fibres; it has been determined in literature that this has little to no effect on the fibre 
length or crystallinity[53, 54]. After homogenization, 100 mL of 1 M NaOH solution (for 
a 250 mL sample) was added. The resultant mixture was then boiled, at a temperature of 
90 °C, for 90 minutes, during which the cell mass was ruptured and removed from 
solution.  
Once treated in the alkaline solution, the cellulose fibres were isolated by centrifugation 
in a DuPont Sorvali® RC-5B refrigerated centrifuge for 20 minutes at 5000 RPM. The 
supernatant was then poured off, more deionised water was added and the process 
repeated 5 times, until the liquid ran clear. Once the last centrifugation was complete, the 
cellulose fibres were then retrieved, bottled and stored in a refrigerator. Weight analysis 
of the concentrated fibrous mass showed a dry cellulose weight of approximately 0.013 
g/mL of sample; although this value varies slightly from batch to batch, this was the 
ascertained average, and was used exclusively in calculations. 
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3.3 Phosphorylation 
3.3.1 Apparatus 
  
 
 
Figure 3.3.1.1: Experimental set-up for the phosphorylation of bacterial cellulose. 
 
3.3.2 Procedure 
In order to phosphorylate the resultant fibres, the water remaining in the cellulose first 
had to be solvent exchanged with dimethylformamide, an aprotic solvent. This was done 
in order to facilitate the addition of phosphate groups without side reactions from residual 
Condenser 
Nitrogen gas inlet 
Round-bottomed 
flask (3-port) 
Mineral oil bath 
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water. The DMF (~50 mL) was added to small quantities of cellulose and shaken to 
distribute the fibres evenly; the solution was centrifuged, the supernatant poured off, and 
more DMF was added. This was done 5 times in order to assure complete solvent 
exchange.  
50 mL of resulting cellulose mixture was then added to a three-port round bottomed flask 
in addition to 15 g of urea and 150 mL of DMF. The flask was placed in a bath of mineral 
oil, and equipped with a condenser and a nitrogen inlet in order to prevent airborne 
contamination. The cellulose was then raised to a temperature of 110 °C, at which point a 
solution comprised of 32 g of orthophosphoric acid dissolved in 50 mL of DMF was 
added to the flask. The mixture was raised to 136 °C, and left to react for up to 8 hours. 
The entire apparatus was allowed to cool to room temperature – maintaining a nitrogen 
blanket – before being removed from the fume hood. The now-phosphorylated cellulose 
was rinsed with deionised water, centrifuged, and stored at 5 °C until required. 
 
3.4 Pre-treatment 
 
Pre-treatment of the phosphorylated fibres took place with the addition of excess 0.1 M 
solution of CaCl2 (or Ca(OH)2 – see section 4.6.2). 100 mL of this pre-treatment solution 
was added to a sample of cellulose, and left to incubate for three days at 37 °C. 
Additional solution was added every day, in an attempt to maintain saturation, and pH 
was tested daily to ensure it was approximately 9. After pre-treatment, fibres were once 
again centrifuged and immediately placed in SBF. 
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3.5 Hydroxyapatite Growth 
 
Kokubo et al. outlined the growth of hydroxyapatite crystals on substrates in several 
papers[8, 55, 56]. The most notable of these is the development of an acellular simulated 
body fluid containing inorganic ion concentrations comparable to that of human blood 
plasma. The idea behind this innovation is to reproduce formation of apatite on bioactive 
materials in vitro, by using a solution of several major ionic constituents of bone. This 
solution is supersaturated in relation to apatite, which alone is relatively insoluble.  
The aforementioned fluid was similarly applied to the production of apatite coatings on 
various materials under biomimetic conditions. Ion concentrations of the simulated body 
fluid (as in comparison with that of human blood plasma) are listed in table 3.5.1 below. 
 
Table 3.5.1: Ionic concentrations in regular (1.0x) SBF and human blood plasma 
Ion Concentration (mmol/L) 
Simulated body fluid (SBF) Human blood plasma 
Na+ 142.0 142.0 
K+ 5.0 5.0 
Mg2+ 1.5 1.5 
Ca2+ 2.5 2.5 
Cl- 147.8 103.0 
HCO3- 4.2 27.0 
HPO42- 1.0 1.0 
SO42- 0.5 0.5 
(adapted from Kokubo et al., 1990[8]) 
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In order to obtain these specific quantities of ionic components, a precise amount of each 
reagent must be added to the solution, and care was taken to assure the accuracy of these 
factors. Variables such as buffering capacity and pH can greatly affect the usefulness of 
the SBF. To this end, the pH of SBF must be adjusted to 7.25 (or 7.40, in certain 
conditions) at 37 °C, and maintained by using 50 mM tris(hydroxymethyl)aminomethane 
((CH2OH)3CNH2) buffer and HCl, as needed.  
 
3.5.1 Preparation of SBF 
The following reagents were procured from their described sources and used to produce 
all batches of 1.5x SBF (in the volumetric increments of 1 L). Solutions of SBF other 
than 1.5 times the concentration in human blood plasma could also be generated (2x, 5x, 
etc.), however, crystallite formation would be significantly harder to control, and crystals 
could possibly be too large to be applicable[57].  
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Table 3.5.1.1: Reagents for Kokubo’s simulated body fluid (1.5x) 
Order of 
addition Reagent Description Amount 
1 H2O  Deionised and Reverse Osmosis filtered 750 mL 
2 NaCl 99.5%, Sigma-Aldrich 11.994 g 
3 NaHCO3 99.5-100.3%, Sigma-Aldrich 0.525 g 
4 KCl  99.5%, Sigma-Aldrich 0.336 g 
5 K2HPO4・3H2O 99.0%, Sigma-Aldrich 0.342 g 
6 MgCl2・6H2O 98.0%, Sigma-Aldrich 0.458 g 
7 1 M HCl 87.28 mL of 35.4% HCl (Sigma-
Aldrich) is diluted to 1000 mL with 
volumetric flask 
60 mL 
8 CaCl2 95.0%, Sigma-Aldrich  
Used after drying at 120 °C for more 
than 12 hours 
0.417 g 
9 Na2SO4 99.0%, Sigma-Aldrich 0.107 g 
10 (CH2OH)3CNH2 99.9%, Sigma-Aldrich 9.086 g 
11 1 M HCl As above (Reagent 7) To adjust pH 
12 H2O As above (Reagent 1) To adjust 
volume 
(adapted from Ohtsuki, 2006[57]) 
 
Kokubo’s simulated body fluid is a meta-stable solution containing both calcium and 
phosphate ions concentrated with respect to the stoichiometric formula of human blood 
plasma hydroxyapatite. In addition, it is supersaturated with respect to apatite solubility. 
Therefore, several meticulous steps in preparing the SBF solution were also deemed 
necessary in order to prevent premature precipitation. 
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3.5.1.1 Cleaning of glassware 
All of the storage bottles, flasks, pipettes, beakers etc. first needed to be washed 
extensively with dilute hydrochloric acid solution and purified water. Contamination 
would potentially disrupt the delicate balance of the solution and cause improper 
formation of HA crystals. 
 
3.5.1.2 Creation of SBF 
The first reagent, 750 mL of reverse osmosis-filtered, deionised water, was poured into a 
1 L glass Erlenmeyer flask. This was continuously stirred and the temperature maintained 
at 36.5 °C via a hotplate and digital thermometer. The remaining chemicals (up to the 
sodium sulphate in the above table) were added slowly to the flask in the order that they 
appear, with constant stirring after each addition to ensure complete dissolution. 
Remnants were washed off of weighing dishes with excess reverse osmosis-filtered, 
deionised water to ensure accuracy of concentration. The addition of the seventh reagent 
(the hydrochloric acid) was performed slowly so as to ensure that no pH ‘hotspots’ were 
created, which might inadvertently cause the premature precipitation of the solution. 
 
3.5.1.3 Adjustment of pH 
The pH meter was first calibrated with fresh buffer solution to maintain sterility. The 
TRIS-buffer (reagent 10) was added to solution. After addition, the temperature was once 
again checked to ensure that it had not fluctuated too wildly. When it was steady at 36.5 
°C, the electrode of the pH meter was placed into solution and the pH was measured. 
Depending on the resultant value, additional HCl was titrated into the solution via pipette 
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until the pH reached 7.25, or 7.4 if the material was not conducive to HA crystallite 
attachment. After adjusting the pH, the entire flask contents were transferred into a clean, 
1000 mL, volumetric flask. The insides of the Erlenmeyer flask were rinsed repeatedly 
with more purified water in order to maintain concentration. Purified water was then 
added to the solution, adjusting the total final volume up to 1 L. The flask was then 
stoppered, shaken vigorously to mix the contents, and left under the fume hood to cool 
down to room temperature before being bottled. If the volume of solution changed 
dramatically whilst cooling, additional water was added to maintain the volumetric level.  
 
3.5.1.4 Storage of SBF 
The solution was then transferred a 1 L polyethylene bottle and stored in a refrigerator for 
several days, at a temperature of 5 °C, before being used. The stability of the solution 
obtained was examined (see section 3.5.1.5) once every couple of days.  
 
3.5.1.5 Testing for Stability 
Before use, 50 mL of the solution was placed into a well-cleaned glass vial with a stopper 
and left in a Revco® Ultima II incubator, set at 36.5 °C. After 3 days, the solution was 
checked for flecks of precipitated HA. If precipitation was present, the batch was 
determined to be unstable and therefore completely unusable. As the solution was 
supersaturated, any bottles in which early precipitation occurred were immediately 
disposed of and could not be used in further experiments. This was done in order to 
prevent the further precipitation of HA in subsequent experiments, as the presence of 
microscopic crystals on the surface of the bottles would immediately nucleate more. 
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For the production of the hydroxyapatite nano-fibres, the cellulotic materials (pellicles or 
fibres) were phosphorylated, pre-treated with Ca ions, and then exposed to 50 mL of 1.5x 
SBF. The mixture was stored in a glass container in an incubator set at 37 °C for two 
weeks. As the cellulose fibres could not be adequately removed from solution without 
potentially disrupting HA growth, the solution needed to be topped up every day to 
maintain concentration. Measurements were made in an attempt to assure constant pH 
throughout the experiment. 
After a period of 14 days, the cellulose was removed and the BC-HA composites were 
characterized via SEM, EDX, FTIR and XRD. 
 
3.6 Characterization 
 
3.6.1 Fourier Transform Infrared Spectroscopy 
FTIR utilizes principles of infrared energy absorption (or transmission) in certain 
chemical bonds to ascertain the nature of those bonds. In addition, as the elements have a 
significant effect on the bond structure, FTIR can often help classify additional 
parameters of the substance, such as entire functional groups, crystallinity and 
concentration. 
In this experiment, samples were characterized using a Bruker® Vector 22 FTIR with 
Attenuated Total Reflectance (ATR) using a Diamond/ZnSe crystal and 64 scans, 
minimum. The samples were either in solid (pellicle or powder) or liquid (loose fibre, 
suspended in water) forms, depending on the nature of the comparison. 
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3.6.2 Scanning Electron Microscopy 
SEM uses a high energy electron beam, in a particular pattern known as a raster scan, in 
order to produce high quality images of the surface of a given substance. Using an 
adequate scanning electron microscope, characteristics such as material fibre diameter 
and extent of deposition, in addition to a multitude of qualitative observations, can be 
found. 
This experiment employed the use of a Leo (Zeiss®) 1530 scanning electron microscope, 
using an accelerating voltage of 2 kV. This voltage was necessary to achieve the highest 
resolution possible without affecting the integrity and condition of the fibre samples. 
 
3.6.3 Energy Dispersive X-ray Spectroscopy 
EDX employs electromagnetic radiation in the form of emitted X-rays to analytically 
characterize matter. By bombarding a sample with a charged beam (usually electrons, 
although, some proton and incident X-ray variations are in existence) and detecting the 
resultant radiation, the electrons in energy shells around a given atom are forced to 
‘jump’ to lower energy adjacent shells, resulting in a characteristic emission that is 
specific to a given element. Using relative concentrations and intensity of these peaks, the 
quantity of each element may also be obtained, in relation to its associated chemical 
components. 
EDX was performed in the lab via the Leo (Zeiss®) 1530 EDX attachment, employing 
Oxford Instruments INCAEnergy™ X-ray Microanalysis software. 
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3.6.4 X-ray Diffraction 
XRD utilizes X-ray beams, which, when striking incident to a sample surface diffracts 
(breaks up) into a variety of reflected points. These points, when taken over a wide range 
of incident angles, provide insight into the chemical bond structure of the sample in 
question, and similarly, can provide insight into the crystallinity of a sample; a 
characteristic which is largely specific only to certain isomers of a compound. 
XRD was performed with the utilization of a Rigaku® MiniFlex™ X-ray 
diffractometer with CuKα radiation, generated at 30 kV and 15 mA. This analysis was 
run over an incident angle range of 5 to 80°.  
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Chapter Four 
4.0 Results and Discussion 
4.1 Overview 
 
The successful creation and development of a novel biomaterial for bone tissue repair 
rests largely upon the extensive investigation into each of its necessary components. 
Although cellulotic biocomposites consisting of hydroxyapatite have been at the forefront 
of technology for several years[49, 58, 59], studies on the combination of said material 
with individual fibres of bacterial cellulose were not conducted. To this end, the major 
factors of the current experimentation are the bacterial cellulose substrate itself, the 
calcium pre-treatment media, the phosphorylation process specific to BC, and the 
SBF/calcium phosphate formulations that will nucleate and cultivate newly formed HA 
crystallites. Significant development and characterization can occur at each level, and 
would ideally contribute to a thicker coating of hydroxyapatite, a finer and more 
crystallized substrate, a higher purity of the complex, and a more malleable and apt 
scaffold material, all of which ultimately result in a higher biocompatibility. The innate 
biomimetic nature of the SBF, in addition to the potential usefulness of increasing the salt 
concentrations from one to five times that of the normal composition, has already been 
examined in numerous perspectives. As such, factors such as the use of varying 
formulations of bacterial cellulose growth media, the effect of bacterial cellulose pellicles 
versus individual fibres and the employ of alternative sources of calcium ions (as 
opposed to the typical calcium chloride solution) for the pre-treatment experiments will 
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instead be evaluated. In addition, the effect of diverse phosphorylation times, and the 
applicability of pre-treatment steps in the general process will be explored. 
 
4.2 Production of BC using Maple Syrup as a Carbon Source 
 
Prior to the investigation into the production of a bacterial cellulotic composite 
biomaterial, the initial aim of this research was to explore the production of its key 
components. Notably, a major goal was to investigate the media composition suitable for 
producing bacterial cellulose via fermentation, utilizing a six-carbon ‘simple’ sugar; this 
traditionally implies fructose (or sometimes glucose) as a carbon source (see figure 
4.2.1). It was therefore postulated that the production of cellulose could be increased or 
otherwise affected by varying the choice of specific sugar.  
In order to facilitate definitive experimentation, distinctly different media formulations 
were incorporated. These media, although employing identical trace element 
compositions and nitrogen sources, significantly differed in their carbon source. The 
rationale behind this change was derived from work by Yezza et al, who, in 2007[60], 
proposed an innovative fermentation media. The research utilized sap from maple trees as 
a novel carbon source, providing the media with carbohydrates in the form of sucrose 
(89%), glucose (5.5%) and fructose (5.5%)[52]. With this research in mind, both a 
formulation using maple syrup (sucrose, amongst other simple sugars), and one 
employing a traditional fructose-based media, were investigated. 
 
  
Figure 4.2.1: Chemical structure of 
fructose 
 
As discussed in a paper by Zeng et al.
sugars in the media does not affe
degree. In fact, the combination of the three sugars discussed above was found to produce 
more bacterial product than sucrose or glucose alone. I
were broken down into fructose and glucose, before being reformed into a cellulose 
chain[60]. This effectively means that the bacteria can metabolize just about any simple 
six-carbon sugar to produce cellulose as a metabolic 
this is done via the Krebs cycl
gluconeogenesis. It is similarly reported by Ross et al., in 1991 that this formation does 
not affect the anabolic processes associated with the bacterial growth, includi
limited to protein synthesis
not affect the growth or survival of the bacteria to any significant degree.
Based on the aforementioned work, and employing a ratio of 1.25 mL of mapl
each gram of required fruct
average yield of cellulose in the case of the fructose
 
 
 
 Figure 4.2.2: Chemical structure of 
sucrose 
 in 2011[52], the presence of alternative si
ct the production of the cellulose to any significant 
n the case of sucrose, the two rings 
by-product. Literature reports that 
e or the pentose phosphate pathway in conjunction with 
[61], implying that resultant cellulose or its predecessors do 
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3.50±0.12 g per litre of media, compared to that of the maple syrup media which was 
found to be 3.14±1.07 g per litre, as seen below in figure 4.2.3. 
 
 
Figure 4.2.3: Weight analysis of dry cellulose per litre of prepared growth media 
 
These results were obtained over the course of two completely independent batches of 
media – formulated from independent sources of maple syrup - with six flask samples 
cultivated from each batch. This indicates that the fructose media is much more 
consistent and reliable, despite the fact that the potential yields for maple syrup media 
appear to be much higher. Understandably, this conclusion is not hard to believe if one 
considers that the maple syrup is, in itself, an inconsistent fluid with a large degree of 
variability in its composition. This assertion is further supported by the fact that the syrup 
had to be pipetted into the flask based on the average concentration of sugars present, as 
calculated based on predicted percentage compositions, provided by the manufacturer. 
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Each source of maple syrup, being treated independently, was likely obtained from 
different trees and/or during different time periods, lending an element of 
uncontrollability to the procurement of any maple syrup standard. As a result, the high 
variation in the amount of product can be credited to the inherent inconsistency of the 
syrup, as well as the relative uncertainty in the sugar concentration as reported by the 
maple syrup farmer.  
One major effect that the maple syrup-based media could have, however, is the possible 
increase of supplementary ions and cursory carboxylic acids, which, in the case of long-
term agitated culture conditions (such as those found in bioreactors or shake flasks), may 
ultimately add to the cellulose yield. The immediate effects may appear to be marginal, 
but previous research[1, 52] has indicated that the addition of miniscule amounts (i.e. less 
than 0.003 g/mL of media) of polyacrylamide, green tea powder, acetic acid, or ethanol 
could have a significant effect on the growth kinetics of the bacterium over longer 
reaction times. Ultimately, this would have the added effect of increasing long term 
bacterial cellulose growth in agitated production conditions. 
 
4.2.1 BC Characterization 
4.2.1.1 SEM Characterization 
SEM characterization of the resultant cellulose, as seen below in figures 4.2.1.1 and 
4.2.1.3, shows similar morphologies and average fibre diameters between samples 
produced in maple syrup and those produced in fructose.  
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Figure 4.2.1.1: SEM of fibres formed from fructose media 
 
 
Figure 4.2.1.2: Fibre diameters for fibres formed from fructose media 
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Figure 4.2.1.3: SEM of fibres formed from maple syrup based media 
 
 
Figure 4.2.1.4: Fibre diameters for fibres formed from maple syrup 
 
According to the fibre diameter distributions shown above (figures 4.2.1.2 and 4.2.1.4), 
the fibre morphology and dimensions are comparable, irrespective of the media 
composition. In fact, whilst the fibre diameters in the fructose sample are 83.9 ± 3.0 nm, 
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those in the maple syrup sample are 100.1 ± 51.7 nm, values that have no statistically 
significant difference.  
 
4.2.1.2 EDX Characterization 
Elemental composition of the BC produced was determined via EDX, confirming the 
presence of carbon and oxygen from hydrocarbons, and is summarized in Table 4.2.1.1 
below. In both the maple syrup and fructose cases of bacterial cellulose, the carbon 
content was found to be around 55% of the atomic weight – excluding hydrogen – of the 
sample (52.89 ± 2.70% and 54.64 ± 0.40%, respectively), with the remainder of the 
sample predominantly comprised of oxygen and negligible concentrations of sodium 
from the purification. As the molecular formula for cellulose is (C6H10O5)n, this is 
legitimate based on idealized stoichiometry. The atomic ratio of carbon-to-oxygen of the 
fructose- and maple syrup-based samples was hence determined to be 1.53 ± 0.13 and 
1.56 ± 0.68, respectively. Although the C/O ratio in cellulose should be 1.2 (based on the 
above stoichiometry of six carbon atoms to every five oxygen atoms), similarities 
between these results at least indicate a parallel in chemical composition. Discrepancies 
are likely due to unavoidable contamination from carbon in the EDX chamber. 
 
Table 4.2.1.1: Summary of EDX results for BC 
 Fructose-based Maple Syrup-based 
Average (%) SD (+/-) Average (%) SD (+/-) 
Carbon 54.64 0.40 52.89 2.70 
Oxygen 35.84 3.29 37.10 8.57 
C/O ratio 1.53 0.13 1.56 0.68 
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These results altogether serve to indicate that there is little to no significant difference in 
the stoichiometry, quality and amount of cellulose produced with regards to variable 
media compositions. Nevertheless, for simplicity and repeatability purposes, fructose-
based samples of cellulose were employed for the remainder of this experiment, although 
it is strongly encouraged that maple syrup-based cellulose samples be pursued as a venue 
for research in the future, due to the potentially high yield of product demonstrated 
above. 
 
4.3 Phosphorylation of BC 
 
In order to phosphorylate the fibres, a mixture of orthophosphoric acid and urea was 
employed, using dimethylformamide as a solvent, held under nitrogen blanketing (see 
Materials and Methods). As the concentrations of the subsequent reactants in SBF were 
fixed by the required ratios of the phosphate involved in HA crystallites 
(Ca10(PO4)6(OH)2), and by the desired amount of HA crystal, the phosphorylation step 
was seen as a means of improving the odds of hydroxyapatite attachment and a full 
cohesive coverage of the fibres. Therefore, the effect of various phosphorylation reaction 
times was studied to determine the conditions for an optimally coated fibre. Traditionally, 
by adopting a procedure from an aforementioned work reported by Wan et al.[6], a 
phosphorylation time of two hours was used, largely based on the principles outlined by 
Fricain et al.[49] and Suflet et al.[62]. The aim of this work was to maximize the degree 
of phosphorylation, in comparable textiles, whilst simultaneously minimizing reaction 
time. The resultant phosphorylated cellulose fibres were subsequently treated with a Ca 
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pre-treatment step (calcium chloride solution) and SBF formulations (1.5x and 5x) to 
varying degrees of success.  
To investigate the effect of reaction time on the phosphorylation reaction, a series of four 
data points, corresponding to 1, 2, 4 and 8 hours of phosphorylation, was proposed. It was 
unpredictably observed that longer phosphorylation reaction times corresponded to more 
cellulose appearing to “precipitate” at the bottom of the container, preventing the full 
removal of the sample. In fact, samples left reacting for 8 hours or more could not be 
removed from the flask at all, and had to be discarded through significant washings. This 
could be associated with a larger degree of substitution of hydroxide groups on the 
cellulose chain, leading to increased solubility of the phosphorylated products, and/or 
degradation of the sample into lower molecular weight fragments (nano-crystalline 
cellulose), which then fused to the glass, rendering them unusable. Nevertheless, samples 
with reaction times of 1, 2 and 4 hours were further scrutinized for data. 
 
4.3.1 Characterization of Phosphorylated BC 
To characterize the products of reactions at 1, 2 and 4 hours after initial exposure, the 
samples were examined via SEM, FTIR and EDX.  
 
4.3.1.1 SEM Characterization 
SEM images of the phosphorylated BC samples in question were used for diameter 
measurements employing image analysis software (ImageJ), and compared to that of 
untreated bacterial cellulose fibres. This was done to ascertain relative fibre diameter and 
 morphology, and to qualitatively interpret the 
follows, in figures 4.3.1.1 and 4.3.1.2
Figure 4.3.1.1: Scanning Electron Microscopy (SEM) outputs of a) untreated BC 
and b) 2 hour phosphorylated BC
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ions, but also provides the previously unanticipated added benefit of increased smaller 
fibre diameter, higher surface area-to-volume ratios, and a better “three-dimensional” 
structure for micron-sized cell attachment and proliferation.  
 
 
 
 
Figure 4.3.1.2: Statistical distribution of fibre diameters in both a) bacterial 
cellulose (105.5 ± 26.0 nm) and b) 2-hour phosphorylated BC (56.7 ± 16.5 nm) 
 
Similarly, after examining the histograms from a statistical perspective, it is postulated 
that the fibres after phosphorylation are more likely to be distributed log-normally in 
comparison to that of the ordinary bacterial cellulose, which has a Gaussian distribution 
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(see figure 4.3.1.2). This is of particular importance, as, historically, the distribution of 
fibre diameters in natural tissue is found to be primarily log-normal[63, 64]. 
 
   
Figure 4.3.1.3: SEMs of BC fibres after 1, 2, and 4 hours of phosphorylation 
 
 
Figure 4.3.1.4: Distribution of BC fibre diameters for samples exposed to 1, 2, and 4 
hours of phosphorylation. 
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analysis via ImageJ confirms this, for 1, 2, and 4 hours of phosphorylation, with fibre 
diameters hovering around 50 nm (56.1 ± 16.3 nm, 50.3 ± 11.7 nm and 51.2 ± 13.5 nm, 
respectively).  
 
4.3.1.2 FTIR Characterization 
As the ultimate goal of the investigation was to use the phosphorylated BC for the 
formation of BC-HA composites, samples were also examined after extended reaction in 
SBF for adequate HA attachment. FTIRs of a ‘BC-HA’ sample, in comparison with the 
same BC after 2 hours of phosphorylation, are shown below in figure 4.3.1.5 over the 
wavelength 950-1200 cm-1. Infrared band assignments are collected in Table 4.3.1.1. The 
FTIR spectrum of untreated BC is also included as a reference.    
 
Figure 4.3.1.5: Sample expansion (950 to 1200 cm-1) of an FTIR taken of a bacterial 
cellulose sample (red), a BC sample after 2 hours of phosphorylation (green) and the 
same sample after 14 days in SBF (blue). The FTIR has been limited in order to 
provide more detail on the significant peaks in this range. 
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Table 4.3.1.1: Wavelength assignment of most significant PO43-/HA peaks (950-1200 
cm-1) 
v (cm-1) Assignment 
985 PO43- in HA[6, 65] 
1004 PO43- asymmetric stretch[65] 
1020 HA nonstoichiometry[65] 
1030 PO43- stretch in HA – strongest peak in 
all FTIRs[6, 65] 
1055 PO43- in HA[65] 
1075 PO43- in HA[65] 
1112 HA nonstoichiometry/acid-phosphate 
containing derivatives[65] 
1145 Acid-phosphate containing 
derivatives[65] 
 
Note that, in figure 4.3.1.5 above, the FTIR trace for the phosphorylated BC mimics that 
of the BC-HA composite material, and both of these correspond with key FTIR peaks 
illustrated by the above table 4.3.1.1. This is indicative of a similarity in chemical 
composition of the two samples, and serves to encourage beliefs that, to some extent, the 
phosphate groups are attached to the cellulose backbone in a means that is conducive to 
inducing HA formation. Similar FTIR traces were produced for the 1 and 4 hour samples 
as well, and will be discussed further in section 4.3.2. 
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4.3.1.3 EDX Characterization 
In order to ascertain the quantitative success of the phosphorylation, the phosphorus-to-
carbon, or P/C, ratio was used. This correlates the amount of quantifiable phosphorus per 
sample relative to the cellulose content of other samples, and allows for comparative 
views of the degree of phosphorylation. To that end, for the 1, 2, and 4 hour samples, the 
P/C ratio was fairly comparable irrespective of the phosphorylation time. Results are 
summarized in figure 4.3.1.6 below. 
 
 
Figure 4.3.1.6: P-to-C ratio for BC samples after 1, 2, and 4 hours of 
phosphorylation 
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This formula results in the following values for the degree of phosphate substitution from 
the phosphorylation reaction alone: 
Table 4.3.1.2: DSP as a function of length of phosphorylation time 
 DSP SD (+/-) 
1 hr 0.147 0.050 
2 hr 0.132 0.123 
4 hr 0.116 0.040 
 
As it can be seen, the P/C ratio seems to hover around 0.025 for all samples of the 
phosphorylated BC, with phosphorus amounting to 1.25% of the sample, on average, by 
atomic weight. Large variability (particularly in the P/C ratio for the 2 hour samples), is 
likely due to varied population size in this particular set of experiments, as well as much 
smaller values for the average, both factors of which exacerbate the apparent difference. 
Using the formula for degree of phosphate substitution described above, this corresponds 
to an average DSP of all samples of 0.133, implying that 13.3% of available –OH groups 
are replaced. This value is comparable to that found previously in literature[66, 67]. 
 
4.3.1.4 Titration Experiments 
Titration experiments were also performed in order to observe the diprotic nature of the 
phosphorylated cellulose. Two millilitre samples were diluted in 50 mL of water and then 
titrated with 1 M NaOH in order to ascertain the extent of the pH inversions. These tests 
followed a predicted pattern, having multiple inflection points in an otherwise smooth 
curve function, and indicating that the protons attached to the phosphate were indeed 
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being systematically reacted, characteristic of a polybasic acid having multiple sites for 
H+ neutralization. The result of this phenomenon is shown below in figure 4.3.1.7. 
 
 
Figure 4.3.1.7: Titration curve for a two hour phosphorylated cellulose sample 
(titrated with concentrated 1 M NaOH). pKa values (determined from the observed 
pH, halfway between equivalence points) confirm the legitimacy of the titration.  
 
From the above graph, 0.6 mL of 1 M NaOH neutralized the first dissociative proton of 
the phosphate group. This implies a molarity of phosphoric acid in the sample of 0.6 
mmols, or 0.3 mmols/mL of cellulose fibre sample. Taking into account the dry cellulose 
weight (0.013 g/mL) and the molecular weight of glucosidic monomer (142.11 g/mol), as 
well as the carbon content of each monomer (6 carbons per monomer unit), one can 
determine the maximum theoretical P/C ratio for the samples of around 0.5. 
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The above titration data leads to a P/C ratio that is approximately 10 times larger than 
that observed via EDX. This may be caused by discrepancies between the techniques 
(molarities are highly sensitive to cellulose bottle weights and concentrations) or 
otherwise by the presence of phosphate groups that could not be washed out by the post-
phosphorylation purification process. The latter is the most likely occurrence, and is 
further justified by the appearance of a subsequent inflection point around a pH of 10, 
which would only be present if the phosphate existed in a PO43- conformation (in the 
phosphorylated BC, phosphates would instead in PO42- form as one oxygen atom is 
covalently bonded to the cellulose backbone). 
 
4.3.2 Characterization of Phosphorylated BC After Treatment in SBF 
Despite the purported necessity of the phosphorylation process in obtaining BC-HA 
composites, the degree to which phosphorylation acts as the de facto nucleation for all 
phosphate groups, or whether it simply just begins the process of phosphate addition, is 
questionable. The subsequent steps (calcium pre-treatment and SBF) both appear in 
literature[6-8] to be key players in producing hydroxyapatitic biocomposites, 
occasionally occurring without adequate phosphorylation beforehand, and, as the 
phosphate must be integrated into the HA matrix beyond that provided in 
phosphorylation alone, an additional source of phosphate ions must be present. As the 
calcium pre-treatment does not contain any phosphorus, the source of these additional 
phosphate groups must be exclusively from the biomimetic SBF treatment. To this end, 
the previous samples, at various phosphorylation times, were compared to the end goal 
Ca/P and P/C ratios of the final composites after treating them in SBF for 14 days.  
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4.3.2.1 FTIR Characterization 
As demonstrated previously in figure 4.3.1.5, employing values outlined in the above 
table 4.3.1.1 of key FTIR peaks, it could be argued that the phosphorylation of the sample 
leads to the formation of further HA-conducive phosphates on the BC. However, 
consideration must be given to the added effects of the subsequent SBF immersion 
reaction, which at first glance appears to provide more significant development of the 
phosphate groups and, ultimately, HA, on the surface of the phosphorylated-BC.  
It should be noted that the FTIR of pure cellulose has several strong, distinct peaks which 
overlap with the desired calcium phosphates, namely those at 1035, 1060, 1110, and 1160 
cm-1 (various vibrations of the C-C and C-O bonds, as well as an asymmetric stretch in 
the C-O-C bond at 1160 cm-1[68]). Hence, peaks at the 1030, 1055, 1112 cm-1 
wavenumbers listed in Table 4.3.1.1 cannot be taken as incontrovertible evidence for the 
presence of PO43- and HA. Nevertheless, remaining peaks at 985, 1004, 1020, 1075 and 
1145 cm-1, taken holistically, provide significant evidence of the success of the 
phosphorylation reaction and the potential for the final HA composite. 
 
 
72 
 
 
 
Figure 4.3.2.1: Expanded FTIR region (950-1200 cm-1) for HA-BC fibre dispersions 
after 1 (blue), 2 (red), and 4 (green) hours of phosphorylation and subsequent 
treatment in SBF for 14 days. The base sample, without any SBF and after just the 
phosphorylation step (2 hours) is also shown (orange). Note the obfuscation of 
significant peaks as discussed earlier (see Figure 4.3.1.5). 
 
Again, the characteristic region for hydroxyapatitic composite materials was determined 
to be between 900 and 1300 cm-1, as previously described by Gadeleta and 
colleagues[65]. Arguably, all of the above FTIRs show the presence of characteristic 
peaks associated with the crystalline forms of the phosphate ion overlaid with that of 
cellulose, in and around 1000-1200 cm-1. These peaks occur irrespective of the form of 
bacterial cellulose sample, or the phosphorylation time. Of note, however, is that in 
increasing the amount of phosphorylation, the FTIR peaks of the sample appear to be 
more defined and emphatic, leading to the hypothesis that the 4 hour sample of BC has a 
higher crystalline deposition of phosphate ions, and thereby hydroxyapatite. This is in no 
way quantifiable without relative intensities; however, it is nonetheless an interesting 
occurrence and one that warrants further investigation. 
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4.3.2.2 EDX Characterization 
 
Figure 4.3.2.2: The Ca-to-P and P-to-C ratios as functions of the number of hours of 
phosphorylation after week long reaction in SBF 
 
As shown in figure 4.3.2.2, phosphorylation time has no effect (not statistically 
significant), on the experimentally determined P/C and Ca/P ratio of the samples after 
reaction in SBF for any significant amount of time. This may be due to the inability to 
isolate the fibres from solution and, because the depleted SBF could not be removed, a 
consistent dilution of the SBF. Centrifugation was thought to be detrimental to the 
crystallite development, as several sources[47, 69-71] implied that the higher forces on 
the HA crystals could potentially cause them to fracture and disperse in the case of large-
scale fibre coating. In hindsight, this supposition is chiefly dependent on the applied 
forces from the centrifugation process, which, based on the crystallite size, is hard to 
justify. Nevertheless, the assumption permeated through the rest of the experimentation, 
causing potential discrepancy in results. 
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The relationship between Ca-to-P ratio and phosphorylation time is shown in Figure 
4.3.2.2, above. As before, it is perceived that sensitivity of the experiment to the length of 
reaction time is minimal. As discussed earlier, the phosphorylated BC samples, with 
reaction times from one to four hours, appeared physically different after removing them 
from the phosphorylation chamber, leading to the belief that the varied phosphorylation 
times generated a significant and quantifiable effect. The fibres appeared to be 
qualitatively more similar to a crystalline solid, becoming more tacky and brittle with 
increasing time in the chamber. However, these phenomena disappeared after subsequent 
washing and purification, with characterization results indicating little difference in terms 
of the Ca/P, P/C and C/O ratio among the samples. This effect is emphasized in samples 
after SBF treatment (Figure 4.3.2.2) as the Ca/P ratio in particular falls within the narrow 
range of 0.5-0.8. Although this ratio is significantly lower than the 1.67 standard 
expected of HA formation, relative similarities hint that it is likely a result of inadequate 
calcium pre-treatment (see Chapter 4.4). Comparatively, the graph below (Figure 4.3.2.3) 
shows this same tendency as tightly grouped series of points by the 14th day; indeed, as 
the phosphorylation time increases, there is conversely very little corresponding increase 
in the observed Ca/P ratio.  
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Figure 4.3.2.3: Ca-to-P molar ratio for samples undergoing 1, 2, or 4 hours of 
phosphorylation time and subsequent SBF reaction 
 
In terms of the phosphorylation reaction time of the sample, at any point in the 
submersion of the sample in SBF, the Ca/P ratio remains relatively constant within 
statistical range. Ultimately, what the above graph implies is that the length of time in 
SBF, instead of length of phosphorylation time, has the desired positive effect on the ratio 
of calcium to phosphate. According to figure 4.3.2.3 above, independent of the 
phosphorylation time, all samples appear to have a smooth grade upwards, plateauing 
around the week-long marker of exposure to 1.5x SBF.  
An interesting point of note here, however, is that the above effect is not exclusive to the 
analysis of the Ca-to-P ratio. In fact, a similar understanding can be drawn about the P-to-
C ratio in all the samples as described earlier. The amount of phosphate on the samples 
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increases dramatically from the first to the fourteenth day in immersion in SBF, an 
increase much more significant than that of transitioning between one to four hours in the 
phosphorylation chamber. The DSP calculation discussed earlier confirms this with yields 
as high as 0.285, by the 14th day of submergence in simulated body fluid, although this is 
largely due to ionic phosphate, rather than PO4 covalently bonded to cellulose. 
Nevertheless, this does confirm that the SBF contributes to a further degree of detectable 
phosphate than the phosphorylation reaction itself. This is consequently understandable 
when considering that the SBF is fine-tuned to increase not only calcium, but also 
phosphate, in ratios mimicking those of hydroxyapatites. 
 
 
Figure 4.3.2.4: P-to-C ratio for samples undergoing 1, 2, or 4 hours of 
phosphorylation and subsequent SBF reaction 
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As seen in figure 4.3.2.4 above, samples with different phosphorylation times all appear 
to have comparable ratios of phosphorus-to-carbon after 14-day submergence in SBF, 
similar to the trend observed in the Ca-to-P ratio earlier. Unfortunately, the variability 
appears to be significantly higher in the above graph, effecting itself in the shown 
standard deviations which are severely exacerbated. This is likely due to the sensitivity of 
the characterization to localized concentrations of phosphate, as well as background 
carbon native to the EDX characterization. Nevertheless, all samples trend upwards, 
again reaching a plateau around day seven, and maintaining an average phosphorus 
content at least equivalent to about 3% of the total atomic weight of the sample, an 
increase from the 1.25% seen earlier.  
In short, the effect of a prolonged exposure of the samples to a phosphate-rich 
environment is negligible on the quantity of the resultant hydroxyapatitic layer, as the 
SBF provides its own phosphate groups. However, this does not negate the possibility of 
an effect from an enhanced crystallinity. In all cases of experimentation above, the 
composites appeared to be largely amorphous, a trend which is often replicated in 
literature[72]. This is justifiable though; the hydroxyapatite found in nature is similarly 
amorphous, owing to the incongruence and imperfection of the natural world. That is not 
to say that efforts should not be made to make samples more crystalline and exact; rather, 
further emphasis should be placed on the creation of a compound with a higher calcium-
to-phosphate ratio and a more significant coating of the fibres (higher yield) rather than 
extending the phosphorylation time for relatively marginal increases in potential 
crystallinity. 
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4.4 Effectiveness of Pre-treatment of BC 
 
In determining the efficacy of the experiment, the potential effects due to the addition of 
a pre-treatment step were also examined. After phosphorylation, the accepted ensuing 
pre-treatment step is to place the sample into a calcium salt solution in the hope that the 
attached phosphate groups would form the initial nuclei for hydroxyapatite. The time 
period for this pre-treatment step is usually one to three days, in similar temperature and 
humidity conditions to the hydroxyapatite growth step, aiding the transition of the 
material from room temperature and acidic pH to the body temperature and neutral pH 
required by the SBF. As such, the typical and predominantly suggested compound for 
this initial reaction was a solution of 0.1 M CaCl2, so chosen for its high solubility, 
relative non-reactivity, and neutral pH. This step is done in the hopes that the resultant 
calcium-phosphate groups would be the nucleating sites for furthering the hydroxyapatite 
growth, in alternating reactions with subsequent calcium and phosphates, whilst 
suspended in the SBF solution. Characterization was performed largely using SEMs and 
EDX, and final crystallite dimensions examined via ImageJ software. 
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4.4.1 SEM Characterization 
 
Figure 4.4.1.1: SEM of pre-treated BC fibres after 3 days in SBF 
 
Interestingly, when the samples are phosphorylated, pre-treated, and placed in SBF, the 
initial growth of calcium phosphate crystallites appears to be almost spherical in nature, 
as seen above. This is confirmed in literature[6, 43, 73], and is believed to be sensitive to 
several factors; the temperature, the adequate and precise concentrations of calcium and 
phosphate in the sample, and the consistently maintained local pH. Unfortunately, as the 
samples were completely suspended in solution and centrifugation was thought to be out 
of the question (crystallites were predicted to shear off by the simple act of agitation[69-
71]), requisite solutions could only be added to the sample, and not removed. This 
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includes solutions used in the pre-treatment and the SBF, and effectively negates the 
potential of any buffering agent. To this end, the pH of the concentrated cellulose sample 
began at approximately 3.6, and occasionally ended at pHs as high as 11, despite repeated 
attempts to adjust and compensate accordingly. It is for this reason that, although samples 
began with these loosely defined, tightly knit, spheres, they all ultimately evolved into the 
platy, rose-like crystals seen in figure 4.4.1.3. 
 
 
Figure 4.4.1.2: SEM of untreated BC fibres after 3 days in SBF 
 
Comparing both the Ca-pre-treated and untreated samples of fibres (figures 4.4.1.1 and 
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4.4.1.2), one can see glaring differences in structure of the crystals, taken at the exact 
same period in development, despite otherwise identical conditions of crystal growth. In 
regards to the latter, when samples are untreated, the crystals, take a significantly shorter 
time to visibly nucleate and grow. Regarding these untreated samples, the SBF must first 
create phosphate binding sites on the phosphorylated cellulose by adding calcium ions, 
cascading down into raw calcium phosphate growth, before ultimately resulting in any 
form of a HA crystal, amorphous or otherwise. This means that there was a severely 
limited amount of usable sites where crystal genesis could take place, and formed crystals 
were likely bigger than their pre-treated counterparts, although not necessarily more 
crystalline or adequately stoichiometric. In maintaining reaction conditions, the crystals 
of either sample still ultimately formed the aforementioned plate-like agglomerates. EDX 
results, in conjunction with speculative FTIR and SEM data in all cases, confirm that 
these are all calcium phosphates, if not hydroxyapatite, albeit with a low crystallinity and 
atypical stoichiometry.  
 
 Figure 4.4.1.3: Comparison of 
day immersion in CaCl
 
The above figure 4.4.1.3 
with a calcium solution m
left, to those after a full 14 days in SBF solution
initially added to the mixture, the qualitative effects are apparently negligible. 
not appear to be more dispersed nor does there appear to be any additional 
nucleation. Instead, the effect manifests itself after the subsequent days of exposure to the 
simulated body fluid. The samples that had the added benefit of a 
calcium solution have a much finer HA crystal deposition, leading to the belief that, with 
enough tuning of parameters, a cohesive and complete coating of the 
established. Comparatively, with the non
 
pre-treated and non-pre-treated samples of BC (3
2) before (left) and after (right) 14-day term in SBF
shows the effects of pre-treating a sample of bacterial cellulose 
ore drastically, by comparing SEMs from the initial complexes
, right. When the aqueous CaCl
pre
-pre-treated analogue, the crystals that form
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instead ‘bulked’ together, usually where fibres have netted together, and appear to be 
much larger (2-3 times) than their pre-treated counterparts.  
 
4.4.2 EDX Characterization 
 
Figure 4.4.2.1: Observed Ca-to-P molar ratio of the bacterial 
cellulose/hydroxyapatite fibre sample over the course of 14 days. The samples were 
tested both with and without the Ca pre-treatment. 
 
The graph above, figure 4.4.2.1, shows the observed Ca/P growth patterns between a non-
pre-treated sample and one that has been pre-treated with calcium ions. Regarding the 
pre-treated samples, the Ca/P molar ratio quickly spikes by the third day in SBF. 
Comparatively, the untreated sample takes more than a week to achieve approximately 
equal amounts of calcium and phosphorus, with a high standard deviation owing to 
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inconsistent deposition. Even then, the Ca/P ratio never comes close to that of the pre-
treated samples. With the Ca pre-treatment, samples were more likely to achieve the 1.67 
molar ratio indicative of the pure HA standard, doing so in the allotted time of 14 days. 
 
4.4.3 Crystallite Dimensional Analysis 
Upon further analysis using ImageJ, it can be shown quantitatively that the diameter and 
length of the resultant crystallites increase with respect to SBF exposure, again, 
dependant on the presence of the pre-treatment step. In order to ascertain the crystallite 
dimensions, it was necessary to model the crystals as cylindrical solids, with their major 
axis running concurrently along the length of the bacterial cellulose fibre. To this end, 
results below show both the length (Figure 4.4.3.1) and diameter (Figure 4.4.3.2) of the 
resultant crystals.  
 
 
Figure 4.4.3.1: Major HA crystallite dimension (length) as a function of the length of 
time in SBF 
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Reasoning behind this trend is as follows. Whilst the non-pre-treated samples must first 
generate nucleation sites by the reaction of Ca2+ with phosphate groups, pre-treated 
samples already possess said sites for subsequent HA crystallization and growth. In other 
words, the most HA conducive sites in non-pre-treated samples occur where HA has 
already been nucleated, and hence, crystals tend to grow bigger instead of nucleating 
throughout. In the samples that have calcium pre-treatment, instead, the crystals attain a 
capped crystal size around 500 nm in length (note that this is the maximum dimension of 
the size of a crystallite, and should not be taken as the fibre diameter), and become more 
prevalent throughout SEMs (see figure 4.4.1.1). With regards to the latter case, this 
means that since the sites of phosphate addition are already seeded with larger deposits of 
calcium ions, there is a better chance of an orderly deposition of phosphates and calcium, 
forming better defined HA crystals. This also consequently explains the higher Ca/P ratio 
observed. In the case of the former non-pre-treated analogues, the substrate-bound 
phosphates must first be reacted with the sparse, ionic calcium in solution, bottlenecking 
the process. This then generates a thinner distribution of nucleation sites, localized ionic 
concentration, and, as a side effect, larger, albeit less stoichiometric, crystals. 
As a corollary to this conclusion, it can also be seen that the maximum crystallite 
diameter is somewhat fixed, independent of the length of time in SBF, although, again, 
samples that have not been pre-treated tend to have a larger dimension along the fibre 
length than their pre-treated counterparts. 
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Figure 4.4.3.2: Minor HA crystallite dimension (diameter) as a function of the 
length of time in SBF 
 
Samples that have not been pre-treated have an average crystal diameter of around 300 
nm; those with Ca pre-treatment instead have a diameter of approximately 190 nm.  
According to literature, however, even these smaller pre-treated crystallites are still 8 
times bigger than expected in comparable experimental conditions. Rusu et al. in 
2005[4], as well as Pang et al. in 2003[74] both found that resultant HA prepared from 
the same chemical precipitation methods after 14 days in aqueous solution had maximum 
dimensions of 53 nm at most, although this was calculated, based on the Scherrer-Debye 
equation and the XRD spectra. This leads to the speculation that the experimental 
samples above are poorly developed sites of calcium phosphate attachment. The 
phenomenon does, however, correlate well with the findings of Wan et al.,[7], who 
ultimately determined that, due to poor calcium deposition in conjunction with a low 
crystallinity (less than 1%) and incomplete coverage of the fibres, crystals are much 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0.5
0 2 4 6 8 10 12 14 16
C
ry
st
a
l 
si
ze
 (
u
m
)
Days in SBF
BCP Crystals
BCPCa Crystals
87 
 
 
bigger than reported in the past, and concentrated in localized areas. In addition, as a 
likely corollary with the low crystallinity and larger crystal size, there is means to believe 
that the larger crystals imply an imperfect stoichiometry and inconsistencies in 
formation[72]. 
Still, the above results indicate that the use of a pre-treatment step causes the nucleation 
of smaller, albeit more stoichiometrically relevant, HA crystals on the fibres. In addition, 
in the course of exposure to the SBF solution, the crystals, irrespective of the pre-
treatment, grow longitudinally, in the direction of the fibre, and not in cross-sectional 
diameter. This effect is made even more dramatic by the maintenance of an apparently 
consistent crystal diameter (depending on pre-treatment) and higher Ca/P ratio, both of 
which suggest that the success of a viable and tunable biomaterial derived from BC and 
HA hinges largely on the essential use of a legitimate Ca-ion pre-treatment solution.  
 
4.5 Characterization of HA 
 
In the above experimentation, it was essential to compare the samples as legitimately as 
possible, relative to their specific conditions, in order to ascertain any form of congruence 
between testing methodology. In addition, the resulting quantities of HA were so small 
that justification of the bona fide crystal could not be made without compromising the 
results of the independent approach. Hence, contamination of the characterization of BC-
HA by artefacts from the BC, the procedure, or the equipment was commonplace. Further 
characterization of the HA itself was abandoned to give way to characterization of the 
88 
 
 
entire composite instead. Nevertheless, it is the assurance of subsequent characterization 
with respect to the HA exclusively that provides evidence to its presence in all 
composites, to varying degrees and purities.  
Samples in all cases were found to possess an arguably congruent FTIR trace, 
reminiscent of that shown in literature[6, 7, 43, 58]. 
 
 
Figure 4.5.1.1: FTIR for hydroxyapatite prepared via biomimetic conditions 
 
The above figure 4.5.1.1 is indicative of the pure hydroxyapatitic sample obtained 
through a biomimetic process identical to that described previously. In order to remove 
the contamination of the sample with the overlapping bacterial cellulose backbone, 
crystals were instead isolated by providing excess calcium and phosphate in the SBF 
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solution and allowing for only HA crystal growth. Small solutions of 0.1 M calcium 
hydroxide and 0.06 M orthophosphoric acid were mixed in the presence of nitrogen[43] 
and then allowed to further precipitate in excess SBF solution, in identical culture 
conditions (temperature, time, etc.) to the composite samples. The resultant mixture, 
which began as a clear solution, soon became precipitated an off-white solid. After 14 
days of SBF submergence (removing the clear upper portion and adding a fresh batch, 
with agitation, every day), at a precisely maintained temperature of 36.5 °C, the samples 
were removed from the incubator, washed with dH2O, and run through a vacuum flask, in 
order to procure the biomimetically-produced HA powder samples. 
90 
 
 
 
Figure 4.5.1.2: FTIRs for, from bottom to top; BC-PO4H2, 1 hr long phosphorylated 
BC-HA, 2 hr long phosphorylated BC-HA, 4 hr long phosphorylated BC-HA, 2 hr 
long phosphorylated HA-Biofill®, and “pure” hydroxyapatite procured via a 
chemical precipitation method in conjunction with SBF. 
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In the above figure 4.5.1.2, similar FTIR peaks are observable throughout the range of 
phosphorylation times (also refer to figures 4.3.1.5 and 4.3.2.1 in earlier sections; note 
the aforementioned overlapping of peaks). Evidence of phosphate groups, suggesting 
both amorphous and pure HA crystallites are seen, in all ranges of the spectrum, as 
indicated by literature. Peaks in the range of 1600-3600 cm-1 should be loosely indicative 
of both the cellulose substrate and the hydroxyapatite, signifying the presence of –OH 
groups and oxygen double bonds (present in carbonated hydroxyapatites[75] and 
phosphorus). This indication is somewhat overshadowed by the fact that the samples are 
contaminated by water and carbonates in the environment as discussed previously. 
However, the peaks in the range from 1500-500 cm-1 (also known as the ‘fingerprint 
region’) remain fairly significant, and noteworthy conclusions can be drawn from them. 
In this range, overlapping peaks from both cellulose and hydroxyapatite can be seen, as 
indicated by figure 4.5.1.3. In fact, the intensities of the peaks are comparable throughout 
the 1, 2 and 4 hour phosphorylations, indicating a similarity and reproducibility of the 
results.  
For the sake of comparison, the FTIR of a 2-hour phosphorylated and SBF-treated sample 
of Biofill®, a commercial bacterial cellulose-based wound dressing, is also shown. This 
then begets an interesting anomaly. Differences in the FTIR trace between the latter 
wound dressing and the former BC fibres are likely attributable to Biofill®’s post-
production method as well as the pre-treatment; dehydration of the sample leads to the 
matrix collapsing upon itself and losing its three-dimensional structure. In this way, the 
improved crystallinity of the substrate bacterial cellulose, in conjunction with the 
assumed physical deposition of the calcium phosphate crystallites on the surface of the 
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sample contribute to the appearance of a much more crystalline HA. This, as such, lends 
itself to a higher intensity on all recorded peaks in the FTIR spectrum. The added side 
effect of this resolve, however, leads to the understanding that the calcium and phosphate 
are being adsorbed onto the surface of the impermeable sample, rather than chemically 
bonded to the individual fibres; a belief that will be expounded upon later. 
 
 
Figure 4.5.1.3: Expansion (900 – 1900 cm-1) of the characteristic region of HA-BC 
composites shown in figure 4.5.1.2 (from bottom to top, phosphorylated cellulose, 1 
hr long phosphorylated HA-BC, 2 hr long phosphorylated HA-BC, 4 hr long 
phosphorylated HA-BC, 2 hr long phosphorylated HA-Biofill®, pure HA. 
 
Overlaying the resultant FTIR spectra, combining them into one graph, and focusing on a 
more specific wavelength range, one can note the similarities of the above graphs (figures 
4.5.1.2 and 4.5.1.3) to the peaks evident in the samples of BC-HA and the phosphorylated 
analogues. The peaks indicated at 3000-3600 cm-1 and 1650 cm-1 are indicative of the O-
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H bond in the hydroxyl group and the ν2 bending of water, as well as the C=O stretch 
from carbonate groups. The former is present in the fact that all materials were suspended 
in solution with water, in addition to ‘normally occurring’ –OH groups necessitated by 
the stoichiometric equation. The latter indicates that the HA is partially substituted by 
carbonate ions (CO32-) from the cellulose, the carbonate in SBF, and ambient carbon 
dioxide, as confirmed by Hong et al., 2006[75]. This is understandable as the literature 
has often reported similar results with similar samples, and is expounded by the fact that 
natural bone mimics this effect of carbonate uptake in its final composition. This may, in 
turn, induce better tissue response, which is a major driving force in such 
experimentation. The last major peak of note is the previously discussed one found at 
1030 cm-1, which, in conjunction with a minor peak seen at 987 cm-1 (and a minor 
overlapping shoulder around 1112 cm-1) is attributable to the stretching mode of PO43- 
vibration (see table 4.3.1.1).  
EDX data shows promise in all samples (including the BC-HA composites), with 
requisite peaks of calcium and phosphate, as well as minor indications of additional 
components such as magnesium, chlorine and sodium found in non-stoichiometric 
hydroxyapatite (akin to that found in bone). Of particular note is the potential for BC-HA 
composites formed using reconstituted Biofill®, which possessed a Ca-to-P ratio as high 
as 1.76 ± 1.46. 
94 
 
 
 
Figure 4.5.1.4: A sample EDX pattern for the BC-HA pellicle samples. Note the 
presence of both phosphorus and calcium in the samples, as well as a trace 
smattering of additional essential elements. 
 
Calcium and phosphorous atoms were detected on the samples (Figure 4.5.1.4, above), in 
varying quantities, depending on the reaction conditions. This serves to indicate that a 
procedure of phosphorylation followed by pre-incubation in the calcium ion solution was 
an effective measure in the stimulation of precipitation on the samples. Ca-to-P ratios 
were taken to ascertain the relative success of the formulation in obtaining true 
hydroxyapatite; ratios should be ideally around the theoretical stoichiometric ratio of 1.67 
for truly crystalline HA, and lower than that for amorphous HA, OCP or TCP. As this 
lower-than-expected ratio is evident in several samples discussed throughout the course 
of this dissertation, it is largely acceptable to claim that the samples contain adequate 
amounts of calcium phosphates, potentially non-stoichiometric amorphous 
hydroxyapatites, or other precursors (tricalcium phosphate, octacalcium phosphate, etc.).  
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Examining the EDX data for hydroxyapatite produced biomimetically without a cellulose 
backbone, the numbers appear to corroborate with the above. The Ca/P ratio is found to 
be 1.51 ± 0.22, which encompasses the 1.67 target. Interestingly enough, the ‘pure’ HA 
sample was found to only contain 53% hydroxyapatite on an atomic weight basis. The 
remainder was a mixture of sodium and chloride; a known impurity derived from the SBF 
formulation (typically rinsed out in successive washings). This is a notable factor which 
helps explain the presence of significant amounts of Na and Cl in BC-HA samples 
discussed previously. Remaining atomic weights are summarized in table 4.5.1.1 below. 
 
Table 4.5.1.1: EDX results for biomimetically produced HA (Ca10(PO4)6OH2) 
Element Theoretical No. 
Of Atoms 
Theoretical 
Percentage 
Actual Percentage 
from EDX 
Ca 10 23.8 20.4 
P 6 14.3 13.8 
O 26 61.9 65.8 
H 2 -- -- 
Total 42 100 100 
 
This table indicates that the actual observed percentage of each element is very close to 
the theoretically obtainable amount of that element in hydroxyapatite. As such, this lends 
credibility to the experimentation, and certainly with regards to the growth of HA 
crystallites and their purity. 
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Figure 4.5.1.5: Sample XRD of the produced HA crystallites. Note the similarity of 
peaks to those discussed in literature, specifically with regards to Markovic et al., 
2004[76], Hong et al., 2006[75] and Saeri et al., 2003[73]. 
 
The XRD spectrum of a sample of the resulting HA is shown above in figure 4.5.1.5. In 
the case of the aforementioned paper by Wan et al.[7], the purity of the sample was 
characterized by the presence of several distinct peaks on the trace, indicated by letters A 
through F. Each of these peaks corresponds to a significant diffraction of a plane of the 
HA crystallites. The corresponding plane is found in table 4.5.1.2 below; in brief, 
however, the strong peaks of 25.8°, 31.8-32.1°, 32.9°, and 34.1° should be noted as they 
are identical to those found by Markovic and colleagues. In addition, the broader swelling 
of the graph underlying the peaks in question is significant as well; known as the ‘halo’ 
effect, it is grounds to believe in an impurity of the crystal and is a general indicator of 
low crystallinity[73]. In this specific case, the broader nature of the peaks, as well as the 
overlapping of the noise evident in the graph, calls into question both the purity of the 
sample as well as the innate deviations in the characterization technique and equipment. 
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Table 4.5.1.2: Assignment of peaks from XRD shown in figure 4.5.1.5 and 
corresponding diffraction planes (adapted from Saeri et al.[73] and Markovic[76]) 
Peak 2θ (degrees) Diffraction Plane 
A 25.8 002 
B 27-29 210 
C 31.8-32.1 211 and 112 (overlap) 
D 32.9 300 
E 34.1 202 
F 39.8 310 
G 46.7 222 
H 49.5 213 
 
Of particular note, the hypothetical location of two significant peaks are indicated by * 
and ** on the above figure 4.5.1.5. These would be the expected locations of extremely 
weak peaks courtesy of the bacterial cellulosic substructure in an adequately produced 
composite structure. The weaknesses of these peaks are expected; Wan et al.[7], noted a 
highly diminished nature of these peaks in their XRD traces of BC-HA after 14 days of 
growth in SBF, attributing it to the advanced thickness and crystallinity of the 
hydroxyapatite crystals on the fibres, which obscure that of the BC. Similarly, the peak 
around 54° is indicative of the above contamination from the sodium chloride salt. 
It is the culmination of all these experimental characterizations that lead to the acceptance 
of the legitimacy of the procedure in its production of potential hydroxyapatite 
deposition, although the fine tuning of the parameters leaves a lot to be imagined. No 
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amount of characterization will lend credibility to a procedure that does not coat the 
fibres entirely or that cannot be controlled by virtue of an inability to wash, centrifuge, 
and otherwise handle the biomaterial. The variability and incongruence of the 
methodology of experimentation itself, and not the samples tested, should be called into 
question, as there were significant roadblocks to the desired adherence to a generally 
accepted procedure. 
 
4.6 Variations in Choice of Pre-treatment Media, and Cellulose 
Morphology in HA Growth 
 
In examining samples that had been pre-treated with calcium ions and left in SBF 
solution, it became necessary to discern a mechanism of calcium attachment to the 
existing phosphate. To this end, several attempts were made to more accurately 
characterize the means by which replicable and more succinct results could be obtained 
by varying factors such as the formation of the bacterial cellulose microstructure and the 
effect of a varied pre-treatment media on the indefinite long term production of HA 
composites. Hong et al.[75] proposed a means by which existing quantities of calcium 
would be ascribed to the adsorption and physical entrapment of molecules via the three-
dimensional network structure of samples, such as BC, in conjunction with the ionic 
interaction of negatively charged phosphates. These salt deposits would then be 
systematically converted into calcium ions, which could then be used in forming calcium 
phosphates. As such, experiments with Biofill®, a bacterial cellulose wound dressing that 
is largely dehydrated, were used to observe the effects of the physical deposition and how 
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it relates to the formation of apatite crystals. Similarly, in several studies[5, 8, 58, 77], the 
use of a calcium hydroxide media for pre-treatment was undertaken. To account for this, 
and to look at a more holistic approach, various pellicles of bacterial cellulose were 
prepared and treated with both types of pre-treatment media - the remaining conditions 
being identical - and characterized via EDX and SEM to examine differences in 
production. 
 
4.6.1 HA-Biofill® Composites 
Compared to the samples of individually suspended fibres, the samples of Biofill® 
appear to have a film of hydroxyapatitic crystals seeded at certain areas of the sample as 
evidenced below in figure 4.6.1.1. 
  
Figure 4.6.1.1: SEMs of the HA-Biofill® composites. The samples of Biofill® that 
were immersed into SBF were found to have variable nucleation sites of 
hydroxyapatite, with areas seemingly barren of HA (A) and areas of significant 
crystallite growth (B) (scale = 1 µm). 
 
In the above SEMs, the small crystallites of HA appear to aggregate and sit on the surface 
of the samples, rather than permeating through them. Whilst this is likely due to the 
A 
B A 
100 
 
 
nature of the Biofill® - specifically, the fact that the drying process effectively closes off 
the trans-material pores - the layering and deposition of pure crystallites gives credence 
to the conclusions drawn from previous results that the Biofill® is more crystalline than 
that of the isolated fibre networks. However, this effect also calls into question the extent 
of the presence of HA in the interstitial width of the never-dried bacterial cellulose 
pellicle.  
FTIRs of the resultant Biofill®-HA composites are shown in previous sections (see 
section 4.4). Although the spectra show the presence of phosphate groups attributable to 
HA, when incorporating the subsequent EDX results it becomes apparent that they also 
possess variable amounts of calcium ions, in addition to the requisite phosphorus. This is 
likely owing to the ability of Biofill® to physically entrap large amounts of calcium, and 
is confirmed with the wide variation of quantifiable calcium phosphates in the EDX 
results. In these samples, a Ca/P ratio of about 1.76±1.46 is observed; as the phosphate is 
consistently 4%, on average, of the atomic weight, this implies that the amount of 
calcium varies uncontrollably, even within the samples themselves. 
 
4.6.2 Calcium Hydroxide Versus Calcium Chloride 
In the course of comparing the competing pre-treatment methodologies, the use of 
calcium hydroxide versus calcium chloride was also explored. Kokubo first took a 
notable stand on this approach in the original published work[8], which proposed such a 
biomimetic synthesis via simulated body fluid. The reasoning at the time was that, due to 
the very specific composition of the media and the scaffold, and the high sensitivity of 
the procedure to factors such as pH, temperature and availability of precipitation sites, the 
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samples would not be adequately coated in hydroxyapatite should there be a harsh 
environment, or if adequate calcium ions could not be provided due to poor solubility.  
As bacterial cellulose was not in mind when the SBF solution was initially considered, 
and in cases where the scaffolds themselves were highly sensitive to pH or lacking a 
certain degree of permeability, this posed legitimate problems with HA growth. This was 
most notably the case in samples lacking a phosphorylation step (instead opting to 
replace functional groups with reactive sulphates, silicate gel, etc.[7, 8, 78]) or in samples 
that were solid/impermeable in and of themselves (such as titanium). Upon the discovery 
of the benefits of phosphorylation however, the prevailing trend soon became to employ a 
calcium salt, with a marginally basic residue group, to neutralize any acidic 
functionalized groups of a phosphorylated analogue; SBF has been shown to nucleate HA 
even in samples lacking any adequate pre-treatment. The most common choice with this 
regard was then calcium chloride, CaCl2, with its high degree of solubility and relatively 
low reactivity; it has, as a result, been used infallibly up until this point.  
To this end, an alternative calcium salt was experimented with to provide some substance 
to the above rationale. The return to the use of calcium hydroxide, Ca(OH)2, as a 
legitimate replacement for the pre-treatment media was entertained by Kokubo et al., in 
subsequent formulations of the SBF media, and has since been employed in all papers 
from this group relating to simulated body fluid synthesis. Mucalo[5, 58] and colleagues 
show a similar reliance, confirming that the supersaturated solutions of calcium 
hydroxide would be a legitimate means of pre-treating their fibres (cotton, at the time), 
with FTIR assuring the presence of calcium phosphate derivatives such as CaHPO4 H2O; 
a known predecessor to octacalcium phosphate and, ultimately, hydroxyapatite.  
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Arguably, the major problem with this form of calcium pre-treatment is the inability to 
acquire high enough molarity in solution, as the solubility of the compound is much 
lower than that of other calcium ion-containing solutions. Similarly, there seemed to be a 
lack of confidence in the calcium hydroxide, perhaps as a predicted weakening of certain 
materials in extended pre-treatment times, as the higher alkalinity of Ca(OH)2 could be 
detrimental to the scaffold. As this is not the case with bacterial cellulose fibres – the 
fibres themselves are purified in concentrated sodium hydroxide – there is little reason to 
become concerned in this particular case. To that end, due to the higher degree of 
alkalinity (pKb = 2.4[79]), the reactivity of a relatively stronger base with a strong acid 
(phosphoric acid in the cellulose) and the lack of introduction of additional cursory ions 
(OH- ions are used in the production of hydroxyapatite as well, as opposed to the chloride 
ion, Cl-, which is not directly used in HA synthesis, but was found in excess in several 
fibre samples), Ca(OH)2 is a potentially adequate pre-treatment media replacement.  
 
Figure 4.6.2.1: Cross section of a BC pellicle pre-treated with calcium chloride 
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Figure 4.6.2.2: Cross section of a BC pellicle pre-treated with calcium hydroxide 
 
To that end, two 10 mm thick, 25 mm in diameter BC-HA pellicles were produced, using 
the procedure for static BC growth discussed previously. Samples were phosphorylated 
and treated with 1.5x SBF as before, differing only in the pre-treatment media 
composition. Observable, qualitative, results of the superiority of calcium hydroxide pre-
treatment are evident in the above SEMs. In the case of the latter image, the 
hydroxyapatite can be seen distinctly as the rough, platy surface of the sample; a factor 
which is not as evident in the CaCl2 analogue. This is akin to the findings of many groups 
in literature - Al-Qasas[43] being a prime example - all of whom report similar forms of 
the calcium phosphate, which, depending on the length of time of immersion, can range 
from spherical crystallites to the ‘rose-shaped’ crystals discussed earlier. In addition, the 
calcium to phosphate ratio is much higher in the Ca(OH)2 pre-treatment, at least on the 
surface of the samples, if not within the pellicle sample. 
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4.6.3 Effect of Pre-treatment Methodologies Internally Within the Pellicle 
In the figures 4.6.3.1 and 4.6.3.2 below, the calcium-to-phosphate molar ratios are shown 
as functions of the depth into the pellicle sample for two samples pre-treated in either 
calcium chloride or calcium hydroxide. In both cases, all the samples were found to have 
an average phosphorus content of 4% of the atomic mass of the sample, similar to 
individual fibre samples produced previously. In addition, although phosphorus-to-carbon 
ratios varied locally, this atomic percentage of phosphorus was relatively maintained 
throughout the thickness.  
 
 
Figure 4.6.3.1: Molar ratio (Calcium to Phosphorus) of the pellicle immersed in 
CaCl2 pre-treatment as a function of the interstitial thickness (each unit of distance 
is approximately 10% of the thickness; standard deviations smaller than the 
markers) 
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Figure 4.6.3.2: Molar ratio (Calcium to Phosphorus) of the pellicle immersed in 
Ca(OH)2 pre-treatment as a function of the interstitial thickness (each unit of 
distance is approximately 10% of the thickness of the sample) 
 
The above graphs show a dependency of the calcium content on the thickness of the 
sample. They indicate that the sample is affected by its tendency to be physically 
deposited, rather than chemically reacted, as trends in the calcium to phosphate ratio 
decrease with increasing depth into the sample. This trend may largely be caused by the 
pH issues stated above, the physical entrapment of calcium molecules, or systematic 
errors inherent to the equipment. However, based on the provided data and researched 
theory, it seems more likely to be indicative of poor permeability. Similarly, the SEM 
images (see figures 4.6.2.1 and 4.6.2.2) appear to show an agglomeration of crystallites 
clearly on the surface of the samples, with a declining amount of apparent crystals 
towards the center. In both samples, there is next to no evidence of crystals as soon as 
one gets to approximately 43.7 µm into the dry sample. This corresponds to 0.2 cm of the 
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wet pellicle, or 20.3% of the dry sample thickness.  
Interestingly enough, however, the phosphorus concentration does not seem to follow a 
similar decreasing trend as one moves through the sample. Instead, phosphorus tends to 
be fairly constant, as emphasized in figure 4.6.3.3 below. 
 
 
Figure 4.6.3.3: Phosphorus content as a function of distance into the sample 
 
In short, the trend indicates that the sample may adsorb larger hydroxyapatite crystals, or 
compounds with higher calcium contents, onto the immediate surface or within the first 
couple of micrometers. This is in direct opposition to the original belief that the sample 
would nucleate significant crystallites within the bacterial cellulose matrix itself, and 
ultimately supports the findings of Hong et al., in 2005[75]. In addition, this is further 
confirmation of the discrepancies in results above; if the samples are not being 
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deposition are not being fully utilized throughout the thickness, then the HA crystals will 
not form on the entire length of the fibre. Instead, the trend is towards a direct crystal 
deposition on certain inconsistent sites upon the surface, which is then likely to be 
washed out in purification or even preparation of samples for characterization. This belief 
also corroborates with the inability to centrifuge the fibres; agitation of this nature could 
induce shear forces that would loosen and otherwise pare away the crystals. Nevertheless, 
this does seem to indicate that it is necessary to provide the samples with some minimum 
amount of agitation to at least expose the potential sites of hydroxyapatite attachment to 
the SBF and/or permit the permeation of calcium deposits. 
The above graphs also appear to confirm that the pre-treatment of the samples with 
Ca(OH)2 benefits the generation of any form of calcium phosphate to a larger extent than 
the CaCl2. In fact, the surface of some of the calcium hydroxide pre-treated samples were 
observed to have a Ca/P ratio much higher than that of HA and closer to that of ‘raw’ 
SBF. This ‘higher-than-theoretical’ ratio indicates the abundance of calcium ions present 
and again corroborates with Wan and Hong in that the molecules of calcium salt are 
being entrapped. Note that this value is theoretically likely to decrease as a function of 
the length of subsequent submersion in SBF; as the concentration gradient gets smaller, 
the depositions similarly decrease. In addition, the weaker alkalinity of the CaCl2 has less 
of an effect on the artefacts left over from the strongly acidic phosphorylation process. 
This phenomenon is confirmed in literature through Mucalo in 1995[58] and Granja in 
2001[59], and is likely attributable to less primary adsorption of Ca ions in the initial pre-
treatment with the –PO4 groups and the –OH groups on the cellulosic backbone, as well 
as the aforementioned ionic entrapment.  
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Due to the understanding that the Ca(OH)2 formulation of the media is more of a 
suspension, and is significantly more reactive to existent acidic functional groups, it is no 
wonder that the samples that were pre-treated with calcium hydroxide possess a much 
higher, yet substantially more variable, Ca/P ratio. Not only are the calcium ions in 
solution reacting with the phosphate groups and becoming physically deposited, but the 
remnant hydroxides are neutralizing any existing protons from the solution. This is 
evidenced by the large increase in the pH of the samples (pH of Ca(OH)2 samples 
hovered around 11; that of the CaCl2 samples was closer to 9). As the fibre dispersion 
samples during titration started at a pH of approximately 3.6, it is apparent that this is in 
fact an acid-base neutralization reaction occurring during the pre-treatment. In addition, it 
is the belief of the experimenter that, as the pre-treatment media is washed out before 
exposure to the SBF (most effectively in the case of the pellicles), this is ultimately a 
more efficient means of reaction; with care and specific exposure times, the variability of 
the pre-treatment media becomes tunable. This advantage potentially becomes moot with 
fibre dispersions though, as, in the absence of a method of isolating the fibres nor any 
significant means of the fibres entrapping calcium, one must be cautious about 
centrifuging after generating any calcium phosphates, lest the nucleation sites be washed 
away. Similarly, as one must aspire to a neutral pH whilst immersed in the SBF 
formulation, and as the centrifuged fibres will ultimately contain some residual alkaline 
solution, this may result in some numerical ambiguity and require further fine tuning of 
parameters. 
Based on this knowledge, it appears that the experimentation could be assuaged into a 
more concrete procedure should the choice of pre-treatment media and the use of 
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pellicles be fine-tuned. Granted, one method seems to preclude the other when individual 
fibres are desired; if one is pre-treating pellicles, the fibres cannot be isolated afterwards 
without blending the sample and breaking up the nucleation sites formed in the scaffold. 
Nevertheless, the use of calcium hydroxide to initially provide sites for HA attachment is 
still a legitimate substitute to the traditional calcium chloride-based solution.  
In short, the addition of calcium hydroxide over calcium chloride as a legitimate pre-
treatment step for producing bacterial cellulose-hydroxyapatite composites is well 
founded. The setbacks that the new media would generate could be easily tempered by 
careful monitoring of the pH in the procedure, and a general understanding of the acidic 
nature of the phosphorylation experiments. In addition, the potential of a physical 
entrapment of calcium into a matrix as a precursor to further calcium ion diffusion 
throughout the sample should not be ignored. There is evidence to the necessity of this 
step, both in literature, and with regards to SEM and EDX data shown above, and this 
thought leaves a lot to consider for individualized fibre composites that lack any three-
dimensional benefit. Nevertheless, the advantages found from this technique are 
significant in that they can ultimately affect the stages of composite production, and the 
accepted understanding of the mechanisms of calcium phosphate crystal attachment. 
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Chapter Five 
5.0 Conclusions and Future Work 
 
Hydroxyapatite, and, in turn, Guided Bone Regeneration, as a veritable means of growth 
and proliferation of human bone cells, has been at the forefront of medical research and 
biomaterial experimentation for several years. Texts as far back as the early 1970s have 
indicated that, in mandibular implantation defects in canines, the addition of 
hydroxyapatitic coatings and semi-permeable membranes promotes the osteointegration 
of foreign materials into the natural tissue with minimal scarring and increased new bone 
formation[41]. Nevertheless, the use of polysaccharide fibrous composites has greatly 
been ignored as the biological necessity of three-dimensional fibres capitulates to the 
simplicity, accessibility and familiarity of a porous, albeit, largely macromolecular (100+ 
µm pore diameter), HA powder analogue. Despite the prevalence of successful 
experimentation on chitin[3], cotton[5, 58], reconstituted cellulose[49], starch[48] and 
collagen[47]-based scaffolds, and despite the allure of the biocompatibility, strength and 
fine fibre diameter of bacterial cellulose, fibre-based HA scaffolds have been left at the 
wayside of an already hindered prospective opportunity. 
That said, individualized fibres of bacterial cellulose-hydroxyapatite composites for 
application in the field of GBR have been explored in the course of this investigation, 
using Kokubo’s Simulated Body Fluid to attach HA to the BC backbone. To this end, 
factors such as the development of the bacterial cellulose substrate, the variability and 
success of the phosphorylation/pre-treatment of the material and the legitimacy of the 
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resultant hydroxyapatite crystals have been tested. Recommendations for the use of 
alterative types of pre-treatment media, and alternate morphologies of the bacterial 
cellulose have been divulged, with the intent of familiarizing the reader with the 
intricacies of the experimentation process and the sensitivity of the product to a multitude 
of tunable parameters.  
Originally, the drive of the experimentation was to develop the composites by elaborating 
upon the procedure for the cellulose production itself. To this end, the carbon source of 
the growth medium was questioned, with maple syrup potentially replacing the traditional 
fructose in the media. Whilst maintaining carbohydrate content in both formulations, the 
effects of the change in sugar were characterized. In experimentation, however, it was 
found that the consequently higher variability in maple syrup sugar concentration 
between batches lead to a similar variability in the beneficial effects. As such, the use of 
maple syrup fell out of favour for the rest of the experimentation. Nevertheless, the 
different formulations of growth media were explored and the structure and functionality 
of the bacterial cellulose was found to be comparable. 
Once bacterial cellulose samples were obtained, it became necessary to perform some 
initial chemical treatment before hydroxyapatite adherence. The initial treatment involved 
a phosphorylation of the cellulose to replace some of the hydroxide groups on the 
backbone with that of phosphates. The reaction placed large, negatively-charged, 
functional groups within the BC resulting in the fibres ‘debundling’ and becoming finer. 
Ultimately, this advanced higher surface area-to-volume ratios, and an improved 
biocompatibility. Length of phosphorylation time was similarly considered, yet was 
found to have a minimal proportional effect on the amount of phosphate attached or fibre 
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diameter. Phosphate substitution of the hydroxides was found to be around 13% of all 
available functional groups - comparable to that found in literature. To this end, the 
phosphorylated cellulose was found to be conducive to the attachment of hydroxyapatitic 
coatings, and independent of the phosphorylation time. 
Pre-treatment was performed using calcium chloride solutions, to react with the 
phosphates now on the cellulose. SBF was used to promote endgame HA precipitation 
and realize the effect of pre-treatment. All samples, again, independent of 
phosphorylation time or pre-treatment, were found to nucleate comparable HA growth 
after 14 days of immersion. An interesting outcome was the discovery that samples 
undergoing pre-treatment initially nucleated less visible crystal growth than their 
counterparts. Samples without any pre-treatment were found to grow larger crystals 
quicker, although they were relegated to localized sites where fibres converged. The 
prevalence of finer crystals in pre-treated samples was much more extensive, however, 
and initially appeared as spheroids before eventually evolving into crystals with sharp 
petals, or ‘squama’, covering the surface. The calcium chloride pre-treatment also 
provided more stoichiometric HA growth; samples that had the pre-treatment step were 
found to more accurately emulate the expected 1.67 Ca-to-P molar ratio for 
hydroxyapatite. In all cases, via FTIR and EDX characterization, the growth of calcium 
phosphates, if not pure hydroxyapatite, was seen on all samples of nanometre-scaled BC. 
The purity of the resultant hydroxyapatite was also tested independently. This was done 
by isolating smaller crystals of amorphous calcium phosphates in aqueous solution, and 
growing them in excess SBF in order to obtain biomimetically-produced analogues. The 
ratio of calcium to phosphate of these samples was found to be 1.51 ± 0.22, which is 
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within the predicted value of 1.67 stipulated by the stoichiometry. FTIR and EDX 
showed the similarity of the compound to calcium-deficient, carbonate-containing 
samples seen in literature. X-ray Diffraction (XRD) experiments confirmed this quite 
effectively, showing evidence of several peaks singularly identical to HA standards, and 
an overall background indicating amorphous regions reminiscent of bone. 
In experimenting on the individualized fibre samples of BC-HA composites, it became 
apparent that the prevalent successes in the field depended on the use of pellicles or pre-
existing, reconstituted forms of fibres for calcium phosphate attachment. To this end, 
sample pellicles were made in accordance with others in literature, and treated with the 
same pre-treatment procedure and SBF described above. Cross-sectional slices of the 
pellicle showed a Ca/P ratio that decreased proportional to the depth, despite a relatively 
constant amount of phosphorus. This implies that samples are more likely to have a better 
quality and concentration of HA growth if they have a three-dimensional structure in 
which molecular calcium can become entrapped, gradually broken down and 
subsequently dispersed. This is similarly confirmed in literature by groups who observed 
a directional growth of legitimate calcium phosphate nucleation sites, dependant on the 
exposure to calcium deposits created in the pre-treatment step[75]. 
In addition to the significance of diffusion in hydroxyapatite growth, the applicability of 
varied pre-treatment media was also tested. In this case, the traditional CaCl2 pre-
treatment solution was compared to a novel calcium hydroxide solution instead. Samples, 
after pre-treatment and 14-day submergence in SBF, were tested via EDX in order to 
ascertain differences. The Ca(OH)2 solution was found to perform better than that of the 
calcium chloride analogue, owing to an increased reactivity, calcium suspensions caused 
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by lower solubility, and the acid-base neutralization of the acidic phosphate group. This 
resulted in a higher superficial Ca/P ratio (more closely approximating native HA), and a 
more significant discrepancy in said ratio between the respective depths into a pellicle 
sample, justifying the belief that similar formulations could perform better in 
individualized fibre dispersions. 
This study has provided greater insight into the techniques and methodology of 
depositing apatite-like crystals on cellulotic biomaterial samples. Founded in this 
understanding comes a significant drive to identify and isolate the successful techniques 
of coating single fibres of cellulose in HA for tissue regeneration purposes. Factors such 
as the potential of Ca(OH)2 suspensions, advancing permeability of the BC substrate 
using agitation or extended pre-treatment times, and the enhanced growth of bacterial 
cellulose using varied growth media should not be ignored. Unfortunately, the current 
experimentation provides indications that a successful technique to produce hollow HA 
fibres is unobtainable with current methodology. Future developments in the field could 
produce the desired bone fibres, which, given time and research, could be extended to a 
growth factor-seeded composite material, with unlimited applicability and variation in 
morphology, along with a high degree of biocompatibility and minimal fear of donor site 
rejection. The field should nevertheless lean towards innovation in the individual fibres’ 
growth and modification, rather than the continued research in the pre-moulded forms, as 
this would ultimately promote the desired mouldability, porosity, and requisite cell 
growth for a legitimate tissue engineering construct in Guided Bone Regeneration 
therapy. 
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